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Abstract 
ABSTRACT 
Emily Pan 
OUTCOMES AFTER ASCENDING AORTIC SURGERY – Registry-based 
Studies with Special Emphasis on Reoperations and Preoperative Cardiac Ar-
rest   
University of Turku, Faculty of Medicine, Department of Surgery, Doctoral Pro-
gramme in Clinical Research; Heart Centre, Turku University Hospital, Turku, 
Finland 
Annales Universitatis Turkuensis, Grano Oy, Turku, Finland 
Surgical repair for ascending aorta regarding an aneurysm or an acute type A aortic 
dissection (ATAAD) share similar principals in techniques. ATAAD is highly le-
thal, and the appropriate extent of surgery at acute setting is an ongoing debate. 
Study I researched the evolution and outcome of ascending aortic surgeries from a 
single centre with 47 years’ experience. Studies II and III utilized one of the 
world’s largest ATAAD databases to investigate the outcome in surgically treated 
ATAAD patients, with a special interest in reoperations and patients that had pre-
operative cardiac arrest requiring cardiopulmonary resuscitation.  
These studies showed that the numbers of ascending aortic surgeries were steadily 
increasing. Patients were older at the time of surgery, but the mortality rate has 
decreased over time. Freedom from reoperations was 95.0% after ATAAD surgery 
at 5 years. In ATAAD patients, isolated ascending aortic replacement without aor-
tic arch involvement did not increase the incidence for a late reoperation, and the 
midterm survival did not differ between the two groups of ascending aortic re-
placement and aortic arch repair. Survival of patients with ATAAD and preopera-
tive cardiac arrest was 50% at 3 years.  
The results after ascending aortic surgeries have significantly improved over time. 
The reoperation rate in Nordic countries was found to be low, and a less extensive 
repair at the initial presentation of ATAAD is sufficient to ensure freedom from 
reinterventions with comparable mortality rates. In patients with preoperative car-
diac arrest, the mid-term outcome was acceptable, suggesting this group of patients 
should not be contraindicated for surgery.  
Keywords: ascending aortic surgery, type A aortic dissection, ascending aortic an-
eurysm, outcome, reoperations, preoperative cardiac arrest 
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Tiivistelmä 
TIIVISTELMÄ 
LL Emily Pan 
NOUSEVAN AORTAN KIRURGIAN HOITOTULOKSET –Rekisteritutki-
muksia aiheesta, mielenkiinnon kohteena erityisesti uusintaoperaatiot sekä 
sydänpysähdyksen saaneet potilaat 
Turun yliopisto, Lääketieteellinen tiedekunta, Kirurgia, Turun kliininen tohtorioh-
jelma; Sydänkeskus, Turun yliopistollinen keskussairaala, Turku, Suomi 
Annales Universitatis Turkuensis, Grano Oy, Turku, Suomi 
Leikkausmenetelmät nousevan aortan kirurgiassa sekä aneurysmalle että akuutille 
tyypin A dissekaatiolle (ATAAD) ovat pitkälti samanlaisia. ATAAD:ssa on hyvin 
korkea kuolleisuus akuutissa vaiheessa, ja siitä, mikä on sopiva leikkaustekniikka 
hätätilanteessa, väitellään jatkuvasti. Ensimmäisessä osatyössä esitetään erään kes-
kuksen nousevan aortan kirurgian kehitys ja pitkäaikaistulokset 47 vuoden ajalta. 
Toisessa ja kolmannessa osatyössä hyödynnettiin yhtä maailman suurimmista 
ATAAD-rekistereistä. Näissä osatöissä tutkittiin Pohjoismaiden kirurgisia hoito-
tuloksia ATAAD-leikkausten jälkeen, keskittyen erityisesti uusintaoperaatiota 
vaatineisiin potilaisiin sekä potilaisiin, joilla oli elvytystä vaativa sydänpysähdys 
ennen leikkausta. 
Nousevan aortan leikkausten määrät olivat tasaisessa nousussa. Leikkaushetkellä 
potilaiden ikä oli aiempaa korkeampi, mutta alkuvaiheen kuolleisuus vähentyi ajan 
myötä. Viiden vuoden kohdalla 95,0 % potilaista ei ollut tarvetta ATAAD-leik-
kauksen jälkeiselle uusintaoperaatiolle. Nousevan aortan rekonstruktio ilman aor-
tan kaaren korjausta primaarissa ATAAD-leikkauksessa ei lisännyt uusintaoperaa-
tioiden määrää aortan kaaren korjauksiin verrattuna. Kolmen vuoden seurannassa 
näiden kahden ryhmän välillä ei ollut eroa eloonjäämisessä. Puolet potilaista, joilla 
oli sydänpysähdys ennen ATAAD-leikkausta, olivat elossa kolmen vuoden koh-
dalla.  
Hoitotulokset nousevan aortan leikkauksen jälkeen olivat selkeästi parantuneet 
ajan kuluessa. Uusintaoperaatioiden määrä Pohjoismaissa oli matala, ja suppeampi 
aortan rekonstruktio akuutissa tilanteessa oli riittävä takaamaan hyvät keskipitkän 
ajan tulokset ilman kuolleisuuden nousua. ATAAD-potilaiden, joilla oli sydän-
pysähdys ennen leikkausta, ennuste kolmen vuoden kohdalla oli kohtalainen. Näin 
ollen näiltä potilaita ei tulisi evätä kirurgisen hoidon mahdollisuutta. 
Avainsanat: nousevan aortan kirurgia, tyypin A aortan dissekaatio, nousevan aor-
tan aneurysma, hoitotulokset, uusintaoperaatiot, sydänpysähdys  
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Hypothermic circulatory arrest 
Hazard ratio 
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MRI 
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Matrix metalloproteinaise 
Magnetic resonance imaging 
Mitral valve repair 
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TGFBR 
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TTE 
the Nordic Consortium for Type A Aortic Dissection 
Odds ratio 
Percutaneous coronary intervention 
Return of spontaneous circulation 
Thoracoabdominal aortic aneurysm 
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thoracic endovascular aortic valve repair 
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1 INTRODUCTION 
The most common thoracic aortic diseases (TAD) are aneurysm and dissection, 
which have many similarities both in aetiology and in treatment. An acute type A 
aortic dissection (ATAAD), the most relevant acute complication of an ascending 
aortic aneurysm, is a life-threatening condition, and one of the most devastating 
surgical emergencies (Goldﬁnger et al., 2014). An enlarged aorta is a strong pre-
dictor for aortic complications (Davies et al., 2002; Elefteriades et al., 2015; 
Juvonen et al., 1997), but patients with an ascending aortic aneurysm (AscAA) are 
usually asymptomatic and ATAAD typically has an unexpected sudden appear-
ance, which make TADs hard to predict or prevent, and therefore much feared. In 
a nationwide population-study including autopsy results, the incidence for TAD 
has been estimated at 12.7 per 100 000 per year with an increasing trend (Olsson 
et al., 2006). 
Once the dissection has occurred, both mortality and morbidity are high (Chiappini 
et al., 2005; Pagni et al., 2013). The pressure of the blood flow tears apart the layers 
of the aorta and exposes the patient to severe organ malperfusions, such as myo-
cardial ischemia and stroke. It is estimated that 22-53% of patients with ATAAD 
die before reaching hospital due to rupture of the aorta, pericardial tamponade 
and/or acute critical end-organ hypoperfusion that caused multi-organ failure 
(Augoustides et al., 2009; Melvinsdottir et al., 2016; Olsson et al., 2006; Spittell 
et al., 1993). Furthermore, up to 17% of patients succumb en route to surgery due 
to severity of the disease and sometimes due to misdiagnosis or diagnostic delay 
(Howard et al., 2013). Among operated patients, perioperative mortality (in-hos-
pital or 30-day) varies between 14.4% to 25.1% (Chiappini et al., 2005; 
Conzelmann et al., 2016; Rylski et al., 2014; Trimarchi et al., 2005).  
The current European Society of Cardiology guidelines from 2014 suggest a 
threshold of 55 mm in maximal aortic diameter for surgical intervention in order 
to avoid disastrous complications in the absence of elastopathy or bicuspid aortic 
valve (Erbel et al., 2014). Once the ATAAD has occurred, the standard treatment 
is an immediate surgery. The extent of the surgery depends on the scale of the 
disease, the risk profile of the patient and the experience of the operating surgeon 
(Augoustides et al., 2011). The immediate goal is to prevent cardiac tamponade 
and coronary artery ischemia, then restore and ensure systemic perfusion by re-
secting and replacing the diseased aorta with an artificial tube. Neurological dys-
functions along with pseudoaneurysms or redissections are the most dreaded long-
term complications following ATAAD surgery. The reoperation rate has previ-
ously been reported at 8.7-13.5%, most commonly related to the formation of a 
pseudoaneurysm (Geirsson et al., 2007; Kobuch et al., 2012; Pugliese et al., 1998).  
10
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There are two notable large international ATAAD registries, the International Reg-
istry of Acute Aortic Dissection (IRAD) (Hagan et al., 2000) and the German Reg-
istry for Acute Aortic Dissection Type A (GERAADA) (Boening et al., 2017). 
Both registries have high volume of patients, but the participating centres vary in 
size, treatment protocols and patient materials. Moreover, the follow-up rate is 
low. Other studies on ATAAD have mostly been single-centre studies with largely 
varied results. Despite many studies been conducted, there is a lack of evidence of 
how the patients perceived as having the most dismal prognosis (e.g. those with 
cardiac arrest) fare and whether an operation is justified. In addition, the appropri-
ate extent of primary ATAAD repair still remains controversial. These and other 
questions gave rise to the idea of a unified Nordic registry – the Nordic Consortium 
for Type A Aortic Dissection (NORCAAD) – that is not only large in volume but 
is also reliable in long-term follow-up and has an ethnically and socioeconomically 
remarkably homogenous population, participating societies with high standards of 
health care, comprehensive national identity registries and access to almost com-
plete follow-up data (Geirsson et al., 2016). 
The objective of this study is to utilise quality registry data from Finland and other 
Northern European countries to determine the incidence and characteristics of 
AscAA and ATAAD, to depict real-life results after TAD surgery, and to provide 
new evidence-based medicine for cardiac surgeons in decision-making process of 
whether to operate and which procedure to choose. 
 
 
 
11
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2 REVIEW OF LITERATURE 
2.1 Anatomy of the thoracic aorta 
Normal aortic wall consists of three layers: the tunica intima – a thin, single layer 
of endothelium, the tunica media – a thick layer of elastic and collagen fibres and 
smooth muscle cells, and the tunica adventitia – an outer layer of mostly fibroblasts 
and collagen fibres. Small capillaries called vasa vasorum supply blood to the 
aorta, and they form a vascular zone on the outer layer of the aortic media.  
The aorta begins from the aortic annulus and continues as a conduit that gradually 
branches into smaller and smaller arteries, eventually into capillaries. The normal 
anatomy of the thoracic aorta is shown in Figure 1. The aortic root is defined as 
the part proximal to the sinotubular junction and consists of the aortic annulus, the 
aortic valve leaflets, the ostia of the coronary arteries and the sinuses of Valsalva. 
The ascending aorta comprises the segment between the aortic root and the right 
brachiocephalic artery. The descending thoracic aorta begins distal to the left sub-
clavian artery and extends to the level of the diaphragm. The aortic arch is the 
segment between the ascending and the descending aorta, and is where the supra-
aortic branches arise to the head and upper extremities.  
2.2 Definition and classification of thoracic aortic diseases (TADs) 
A thoracic aortic aneurysm is often defined as a segmental dilatation of > 50% 
compared to the normal diameter or size beyond 40 mm (Hiratzka et al., 2010; 
Johnston et al., 1991). The normal size of the aorta is influenced by age, gender, 
ethnicity and body surface area. The size also varies depending on the cardiac cy-
cle, the segment of the aorta, the imaging modality, and the interpreter of the study. 
Therefore, an absolute uniform cut-off measurement to define an aortic aneurysm 
is not possible. 
Aortic dissection occurs when the inner layer of the aortic wall, known as the in-
tima, is perforated with a tear, and the blood flow dashes between the intima and 
adventitia creating a false lumen and dissects along the aorta. The dissection can 
progress both anterogradely and retrogradely. The site where the tear originates is 
called the primary or entry tear, and can often be visually identified on different 
imaging modalities by an intimal flap. 
12
31157481_Vaitoskirja_Emily_Pan_Laaketiet_tdk_sisus_B5_2606.indd   12 26.6.2019   9.12
14 Review of literature 
 
Figure 1.  Anatomy of thoracic aorta. 
 
Figure 2.  Stanford and DeBakey classifications of aortic dissection. Pub-
lished with permission from the copyright holder, Professor Tomas 
Gudbjarttson. 
13
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There are two widely adopted classifications of aortic dissections, both based on 
anatomy; the Stanford and the DeBakey classifications (Figure 2). Stanford type 
A aortic dissection involves the ascending aorta, whereas in type B, the dissection 
solely affects the descending aorta (Miller et al., 1979). DeBakey type I accounts 
for both the ascending and the descending aorta, type II covers only the ascending 
part and type III the descending segment (Debakey et al., 1965). Aortic dissection 
can also be divided into acute and chronic phases. The morbidity and mortality 
rates are highest during the acute phase, which is defined as less than 14 days from 
the onset of the first symptoms.  This thesis focuses on acute Stanford type A aortic 
dissection.  
The Penn classification is based on ischemic presentation in ATAAD, and is used 
to stratify patients by operative mortality risk. Penn Class A applies to patients 
without any branch vessel malperfusion or ischemia, Penn Class B refers to local-
ized ischemia with branch vessel malperfusion and signs of organ ischemia (e.g. 
stroke, renal failure, mesenteric ischemia) and Penn Class C stands for generalized 
ischemia with signs of circulatory collapse. When there are signs of both localized 
and generalized ischemia, Penn Class B&C is used. (Augoustides et al., 2009) 
2.3 Aetiology, pathogenesis and predisposing factors for TADs 
2.3.1 General  
In TADs, it is known that the genetics plays an important role (Ahmad et al., 2017; 
Isselbacher et al., 2016). Despite similar manifestation during complications, the 
aetiology and pathogenesis of an AscAA is significantly different from a descend-
ing aortic aneurysm or abdominal aortic aneurysm that are predominantly related 
to acquired pathologies (Vapnik et al., 2016). Regardless of aetiology, the for-
mation of an aneurysm is eventually caused by medial degeneration. The mecha-
nism for this process is multifactorial and can be caused by genetic mutations, in-
flammatory changes, acquired conditions, or be purely sporadic. Predisposing fac-
tors for thoracic aortic aneurysm and ATAAD are listed in Table 1. 
 
14
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Table 1. Risk factors for acute type A aortic dissection. Apart from trauma 
and iatrogenic causes, the same risk factors are also valid for as-
cending aortic aneurysms. 
Heritable causes 
Heritable connective tissue diseases 
     Marfan syndrome 
     Loeys-Dietz syndrome 
     Ehlers-Danlos syndrome 
Other familial thoracic aortic disease 
Turner syndrome 
Bicuspid aortic valve 
 
Inflammatory causes 
Vasculitis 
Takayasu arteritis 
Giant cell arteritis 
Bechet disease 
Syphilis 
Tuberculosis 
 
Acquired causes 
Atherosclerosis 
Hypertension 
Increasing age 
Smoking 
Cocaine and other stimulant abuse 
Repetitive heavy weight lifting 
Trauma 
Previous cardiac surgery 
Iatrogenic 
Cardiac catheterization 
Insertion of intra-aortic balloon pump 
Aortic cross-clamping 
 
15
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2.3.2 Medial degeneration 
A histopathological examination of an aneurysmatic aortic tissue reveals degrada-
tion of the extracellular matrix (ECM) in the tunica media. This is often described 
as cystic medial necrosis that is characterized by fragmentation and loss of elastic 
fibres, degradation of collagen, depletion and atrophy of vascular smooth-muscle 
cell (SMC), and mucoid deposition. SMC and ECM proteins, like collagens and 
elastin fibres, give strength and integrity to the aortic wall so it can response to 
each cardiac pulsation with elasticity and flexibility. The degradation of these 
structural components causes the process of cystic media necrosis and weakening 
of the aortic wall, which eventually may lead to aneurysm formation and tear on 
the wall. (El-Hamamsy & Yacoub, 2009; Isselbacher et al., 2016; Milewicz et al., 
2017) 
The exact mechanism leading to medial degeneration is not fully understood. It is 
known, however, that regardless of the aetiology, the immune-inflammatory mech-
anisms significantly contribute to aortic wall degradation and remodelling. Acti-
vation of macrophages in the tunica media releases and regulates matric metallo-
proteinases (MMPs) and several pro-inflammatory cytokines that are pivotal in 
triggering and maintaining the ECM degradation and neoangiogenesis. The imbal-
ance between MMPs and MMP tissue inhibitors is the key in the early process of 
aneurysm formation. (Cifani et al., 2015; Danyi et al., 2011; Ikonomidis et al., 
2006; Tamarina et al., 1997) 
2.3.3 Heritable causes 
2.3.3.1 Heritable connective tissue diseases 
Connective tissue diseases are a heterogeneous spectrum of heritable disorders that 
affect various organ systems including ocular, musculoskeletal, pulmonary, and 
cardiovascular systems. They all cause defects in the structure of ECM, and there-
fore have significant phenotypical overlapping (Bowen et al., 1987; Meester et al., 
2017) 
Marfan syndrome is an autosomal dominant heritable disorder that is caused by a 
variety of mutations in the FBN1 gene that encodes a large ECM protein called 
fibrillin-1. This protein forms elastic fibres and interacts with signalling cytokine 
called transforming growth factor- (TGF-), which in turn controls cell differen-
tiation, motility and proliferation (Biery et al., 2002; Isselbacher et al., 2016; 
16
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Verstraeten et al., 2016). The increased activity of TGF-, as well as increased 
MMP signalling, elastin fragmentation, vascular smooth muscle cell apoptosis, 
macrophage chemotaxis and inflammation lead to histopathological findings in the 
aortas of patients with Marfan syndrome (El-Hamamsy & Yacoub, 2009). The 
most typical cardiovascular abnormality in Marfan syndrome is a pear-shaped di-
lated aortic root, also referred to as annulo-aortic ectasia. It is reported that up to 
5% of ATAAD patients have Marfan syndrome (Evangelista et al., 2018) and up 
to 80% of unexpected deaths in Marfan syndrome were caused by aortic compli-
cations, such as dissection or rupture (Groth et al., 2017; Murdoch et al., 1972). 
Although Marfan syndrome is a heritable disorder, 25% of patients present spo-
radic mutations without known family history (Milewicz et al., 2005). 
Loeys-Dietz syndrome (LDS) is another type of connective tissue disorder that is 
caused by mutations in TGFBR1 or TGFBR2 (transforming growth factor beta 
receptor) genes, which are encoded by TGF-. From the cardiovascular perspec-
tive, LDS is associated with arterial tortuosity, aneurysms, and dissections in the 
vascular system. Up to 98% of LDS patients have an aortic root aneurysm, and the 
most common cause of death is thoracic aortic dissection (Loeys et al., 2006).  
Ehler-Danlos syndrome (EDS) is a diverse group of clinically and genetically het-
erogeneous diseases that are caused by mutations of COL3A1, which results in a 
defect in type III collagen synthesis. Up to 25% of these patients have an aortic 
aneurysm (Verstraeten et al., 2016) and up to 78% of EDS and their affected rela-
tives die from aortic dissection or rupture (Pepin et al., 2000). 
Apart from the above-mentioned, many patients who do not have connective tissue 
features are still discovered to have mutations in the TGF- signalling pathway, 
suggesting there’s much wider phenotypic variation in the manifestation of con-
nective tissue diseases. In addition, up to 21.5% of these patients were found to 
have a first-degree family member with an arterial aneurysm (Albornoz et al., 
2006). 
2.3.3.2 Other familial TADs 
Mutations in genes that encode smooth muscle myosins and actins, fibrillin-1, and 
MMP-17 are linked to familial TAD. These result in dysfunction of the vascular 
smooth muscle of the tunica media and will eventually lead again to medial degen-
eration. Familial TADs generally present at an earlier age (56.8 years) than patients 
with sporadic TADs (64.3 years) (Coady et al., 1999). 
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2.3.3.3 Bicuspid valve 
A bicuspid aortic valve (BAV) is the most common congenital abnormality affect-
ing the aorta, and it is a well-known risk factor for aortic aneurysm formation, 
dissection and rupture (Larson & Edwards, 1984). BAV is noted in 4.9-7.5% of 
patients with TAD (Roberts & Roberts, 1991; Trimarchi et al., 2005), while only 
in 1-2% in general population (Roberts & Elliott, 1968). A series of patients with 
BAV showed that the relative risk for developing an aortic aneurysm sized  50 
mm was 26 times higher and aortic dissection occurred 8 times more frequently 
when compared to an age-adjusted general population (Michelena et al., 2011). 
The association between a BAV and aortic dilatation or dissection has also been 
linked to genetic deficiencies of aortic fibrillin, apoptosis of vascular smooth mus-
cle cells, and upregulation of MMP, which lead to medial degeneration and weak-
ening of the aortic wall (Bonderman et al., 1999; Fedak et al., 2003; Verma & Siu, 
2014). In addition, the morphology of a bileaflet valve makes it more prone to 
calcifications compared to trileaflet valves. This can lead to both aortic valve ste-
nosis and aortic regurgitation, which may increase the aortic wall tension and thus 
cause dilatations (Siu & Silversides, 2010). According to the Sievers classification 
of BAV, the morphology of BAV with two raphes has a significantly higher pro-
portion of aortic aneurysms compared to none or one raphe (Ridley et al., 2016; 
Sievers & Schmidtke, 2007). Irrespective of morphology, the tubular ascending 
aorta is the most commonly dilated segment of aorta in patients with BAV – up to 
60% – and has the fastest growth rate in patients without Marfan syndrome. Pa-
tients with Marfan syndrome typically have the maximal aortic dilatation at the 
level of Valsalva sinuses. In contrast, the sinus of valsava is dilated in 27% of 
patients with BAV and it is associated with typical BAV morphology (Detaint et 
al., 2014). In the original Sievers and Schmidtke series that only included operated 
BAVs, 6% had aortic root involvement, 29% involved ascending aorta and  1% 
had aneurysms in the arch or descending aorta (Sievers & Schmidtke, 2007). 
2.3.4 Inflammation 
Any inflammatory aortic disease may result in aortic dilatation. It is typically char-
acterised by various degrees of inflammation both in the media and the adventitia. 
This causes fibrous intimal thickening and medial injury that can sometimes 
evolve into medial infarction leading to laminar medial necrosis if the vasa vaso-
rum are involved. Necrosis of the vasa vasorum may in turn cause bleeding inside 
the aortic wall, a condition that is known as intramural haematoma.  
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In vasculitis, especially in giant cell arteritis and Takayasu aortitis, adventitial fi-
brosis with inflammation of the vasa vasorum, medial necrosis and scarring, fi-
brous intimal thickening and a grossly tree-bark appearance can be found.  Sys-
temic diseases like sarcoidosis, lupus erythematosus, rheumatoid arthritis and an-
kylosing spondylosis may also affect the aorta, causing inflammation and predis-
pose to aortic complications (Tavora & Burke, 2006) . 
Infectious aortitis can be caused by syphilis and various haematogenically dissem-
inated organisms (Roberts et al., 2015). Although very rare, these conditions may 
cause massive AscAAs which can erode the aortic wall leading to dissection or 
rupture (Tavora & Burke, 2006). 
2.3.5 Acquired causes 
In acquired diseases, the formation of AscAA is mostly caused by increased aortic 
wall stress. The tension on different parts of the aortic wall varies significantly as 
dictated by LaPlace’s law; the larger the diameter, the higher the pressure against 
the wall (Hademenos et al., 1994).  
Hypertension is the most significant condition that elevates wall stress. Higher sys-
tolic blood pressure has been shown to be linearly correlated to increased wall 
stress, and the increase is even more significant the larger the diameter of the aortic 
wall has (Rabkin & Janusz, 2013). Hypertension also indirectly cultivates aneu-
rysm formation by triggering pro-inflammatory condition on the aortic wall. En-
larged arteries are in danger of a tear, as the tears usually occur at the point where 
the wall tension is the most prominent. Anatomically, the sinus Valsalva has the 
largest diameter of the aorta. Therefore, the tear often begins at the sinotubular 
junction or the root of ascending aorta.  
Atherosclerosis is an acquired disease which has non-infectious inflammatory 
components that primarily affects the intima. Although it is more commonly re-
lated to the descending and abdominal aorta, it can be encountered in the ascending 
aorta. Endothelial injury caused by rupture of an atherosclerotic plaque may trigger 
a dissection (Maleszewski, 2015).  
Being an elastic wall, the tensile limit can be reached by aneurysm formation, and 
a large aneurysm itself predisposes to greater increments in growth, increasing thus 
the risk for dissection or rupture (Elefteriades & Ziganshin, 2015). The median 
AscAA size at the time of rupture or dissection is 60 mm and < 50 mm for patients 
with Marfan syndrome (Coady et al., 1999). Yet, a dissection may occur without 
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a pre-existing aneurysm. In fact, up to 60% of ATAAD occurred at the aortic di-
ameter of < 55 mm and 40% < 50 mm (Pape et al., 2007).  
Increasing age, male gender and smoking are associated with ATAAD. Age in-
creases the stiffness of the aorta and the formation of atherosclerotic plaques and 
is a significant risk factor for both aortic aneurysm formation and a dissection. 
Smoking may contribute to the inflammatory components of medial degeneration. 
Not only it increases the risk for dissection but it might also be responsible for 
more rapid growth of the aortic aneurysms (Kihara et al., 2017). 
Cocaine or stimulants use, aortic coarctation, pheochromocytoma, stress and phys-
ical trauma (especially blunt trauma) to the chest can raise the aortic wall stress 
temporarily and predispose to dissection (Ahmad et al., 2017). 
Other acquired causes for ATAAD include iatrogenic incidences due to invasive 
procedures, such as percutaneous coronary intervention (PCI), open cardiac sur-
gery, arterial cannulation and other arterial manipulations, especially among older 
patients with cardiovascular risks (Ramanath et al., 2009). As many as 5% of all 
aortic dissections were found to be iatrogenic, most commonly related to cardiac 
surgical procedures (Januzzi et al., 2002). Previous cardiac surgery, chronic aortic 
dissection, and post-traumatic aortic transection are also risk factors for an aortic 
aneurysm. Diabetes and dyslipidaemia, which contribute to the formation of ath-
erosclerotic plaque, do not seem to be directly associated with TAD (Achneck et 
al., 2005). 
2.3.6 Vasa vasorum 
Apart from medial degeneration, another hypothesis regarding the development of 
ATAAD suggests a progression from intramural haematoma (IMH). IMH is 
caused by bleeding into the aortic media due to small, spontaneous ruptures in the 
vasa vasorum. It has been suggested that the mass effect of IMH weakens the aortic 
wall by increasing the stress on the intima, and therefore exposes to an entry tear 
(Harris et al., 2012a). Although IMH does not have an intima tear, the progression, 
management and prognosis of the type A IMH is similar to ATAAD (Goldberg et 
al., 2014; Harris et al., 2012b)  
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2.4 Epidemiology of TADs 
2.4.1 Incidence of TADs 
A large population-based study reported an incidence of 16.3/100,000/year for 
male and 9.1/100,000/year for women in TADs. The incidence for thoracic aortic 
aneurysm alone is reported around 10.4/100,000/year (Clouse et al., 1998) and for 
ATAAD is estimated at 2.53-6/100,000/year (Howard et al., 2013; Yeh et al., 
2015).  
An increasing trend in the incidence of TADs has been noticed in several studies 
(Clouse et al., 1998; Olsson et al., 2006), albeit it is difficult to tell to what extend 
it can be attributed to incidental findings, better diagnostics, and aging of the pop-
ulation. TAD is a clinically predominantly silent disease, and while it is estimated 
that 22% of TAD patients end up with a complication (dissection or rupture) 
(Albornoz et al., 2006), up to 95% of patients are asymptomatic before a compli-
cation occurs (Kuzmik et al., 2012). On the other hand, one quarter of patients with 
ATAAD do not reach the hospital alive and their diagnosis is made at autopsy 
(Melvinsdottir et al., 2016; Olsson et al., 1993). In contrast, a whole-nation study 
that included autopsy results showed a stable incidence of ATAAD (Melvinsdottir 
et al., 2016). These elements make determining the true prevalence of AscAA and 
incidence of ATAAD challenging.   
2.4.2 Demographics of ATAADs 
The mean age of patients presenting with ATAAD is typically around 60 years, 
women being significantly older than men, but two-third of patients are male. 
Marfan syndrome is present in 5%, atherosclerosis in 23.8%, known aortic aneu-
rysm in 12.7%, prior aortic surgery in 14.2% and previous acute aortic dissection 
in 4.0% of ATAAD patients (Evangelista et al., 2018). 
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2.5 Diagnosis of TADs 
2.5.1 Clinical symptoms and findings 
Dilatation of the ascending aorta is an indolent process, and patients with AscAA 
are most of the time asymptomatic. Nevertheless, depending on the size and loca-
tion of the aneurysm, a wide range of very rare and nonspecific symptoms can be 
found, such as throbbing of deep chest pain that can spread to the back, shortness 
of breath, cough, dysphagia, and hoarseness due to laryngeal nerve palsy (Erbel et 
al., 2014). 
The clinical manifestation of ATAAD is very diverse and up to 21% report not 
having any chest pain initially (Hagan et al., 2000). Typically, however, the onset 
of ATAAD is abrupt and dramatic. The most common presentation is severe pain 
that is often described as sharp, tearing or ripping retrosternal chest pain that radi-
ates to the back (Pape et al., 2015). Some 13-19% are reported to have syncope 
during initial presentation (Nallamothu et al., 2002). Initially, patients tend to be 
hypertensive but often become hypotensive at later settings. Upon clinical exami-
nation, approximately 44% have aortic insufficiency or newly detected murmur, 
and pulse defect can be present in 31% of patients (Trimarchi et al., 2005).  
Younger patients (< 40 years) tend to present without hypertension and are more 
likely to have a bicuspid valve, connective tissue disease, to have undergone prior 
aortic valve surgery, and the origin tends to be more proximal (Januzzi et al., 
2004). Elderly patients are more likely to be hypertensive at presentation, to have 
a coexisting aneurysm, to have had a prior cardiac surgery and to have more 
comorbidities, such as atherosclerosis and diabetes (Mehta et al., 2002). 
2.5.1.1 Complications 
In ATAAD, preoperative malperfusion syndrome is a feared complication caused 
by obstruction or occlusion in arteries that can lead to end-organ failures. It is pre-
sent among 30-40% of ATAAD patients and is a major risk factor for both in-
hospital and long-term mortality (Czerny et al., 2015; Eusanio et al., 2013; 
Narayan et al., 2017; Zindovic et al., 2019).  
Renal insufficiency is estimated to be present in 18% of ATAAD patients and as-
sociated with significantly increased in-hospital mortality. Acute limb ischemia 
was reported in 9.7% and major brain injury approximately in 10-20% of ATAAD 
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(Berretta et al., 2016; Eusanio et al., 2013; Weisberg et al., 2019). Patients with 
mesenteric ischemia, although rare, are noted to have highest mortality, up to two-
thirds of cases (Evangelista et al., 2018). 
When the dissection progresses retrogradely towards the aortic root and coronary 
arteries, it may cause coronary ischemia and severe aortic insufficiency that can 
lead to acute cardiac failure. Ruptures again may lead to cardiac tamponade, 
hypovolemic cardiogenic shock and eventually to cardiac arrest. Cardiogenic 
shock or pericardium tamponade can be registered in 13-18% of ATAAD patients 
before the surgery (Bossone et al., 2016; Evangelista et al., 2018).  
2.5.2 Diagnostic imaging 
A computed tomography (CT) with contrast agent is the golden standard for diag-
nosing TADs. It is fast, nowadays easily accessible, and both its sensitivity and 
specificity are nearly 100% (Mussa et al., 2016) (Figure 3). With 3D reconstruc-
tion, it can accurately show the measurements of aneurysms, an intimal flap, a 
penetrating ulcer and separate between an intramural haematoma and an aortic dis-
section. The downside of CT include exposure to radiation and the risks for con-
trast induced nephropathy.  
Echocardiography provides a fast and easy way to get high-resolution, real-time 
images of cardiac function, anatomy of the valves, the aortic root, and the proximal 
aorta. It can be performed either transthoracically (TTE) or transesophagecally 
(TEE). TTE is non-invasive and can be done bedside, while TEE is a semi-invasive 
procedure but provides a better view of the entire thoracic aorta and is often rou-
tinely used during valve procedures to monitor cardiac function. The sensitivity of 
TEE in ATAAD approaches 86-100% with specificity of 90-100% (Mussa et al., 
2016; Sobczyk & Nycz, 2015). However, they have limitations such as poor visu-
alization of intramural haematoma, entry tear location and the aortic arch, and they 
often do not reveal the whole extent of the dissection.  
Cardiac magnetic resonance imaging (MRI) shows the aortic valve and ventricular 
function, and provides precise measurements of the entire aorta, especially when 
combined with angiography. It is very accurate and does not emit ionizing radia-
tion. On the other hand, it is time-consuming, more expensive, less readily availa-
ble, contraindicated in patients with metallic foreign bodies and typically not suit-
able in the acute setting. It can also cause systemic nephrogenic fibrosis in patients 
with advanced renal failure (Mussa et al., 2016). 
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AscAA and ATAAD can be both revealed by a widened mediastinum on a stand-
ard chest X-ray. A plain chest X-ray is, however, not sensitive nor specific and 
certainly not diagnostic, but due to its simplicity and easy access, most patients 
end up having a chest x-ray first before the diagnosis is confirmed. A widened 
mediastinum can also lead to suspicion of a thoracic aortic pathology when not 
suspected before imaging. 
 
 
Figure 3. An axial plane of enhanced CT scan showing dissected aorta at the 
level of pulmonary truncus. Published with permission of the copy-
right holder, Professor Tomas Gudbjarttson. 
2.5.3 Biomarkers and other diagnostic tools 
D-dimer is a fibrin fragment found in coagulopathic disorders, such as in ATAAD. 
It has a high sensitivity for detecting ATAAD and is typically significantly ele-
vated during the first hours after ATAAD, in contrast to other conditions where D-
dimer elevates gradually. In low to intermediate suspicion of ATAAD, a negative 
D-dimer within the first 24 hours after symptom onset is most likely sufficient to 
rule out the disease (Rogers et al., 2011; Sobczyk & Nycz, 2015; Suzuki et al., 
2009). A positive D-dimer, however, should raise suspicion for ATAAD but can 
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be related to many other conditions, including life-threatening pulmonary embo-
lism (Nazerian et al., 2018). Several other biomarkers for AscAA and ATAAD are 
under investigation, but so far none of them are in clinical use (Suzuki et al., 2008) 
An electrocardiogram (ECG) is not sensitive nor specific for aortic dissection. In 
the IRAD database, up to 40% of patients with thoracic aortic dissection have a 
normal ECG (Costin et al., 2018). Changes on ECG are secondary to dissection 
extending to the coronary arteries causing coronary ischemia and/or cardiac tam-
ponade. Therefore, negative T-waves, ST-segment elevations or depressions, or 
low-voltage may be encountered (Kosuge et al., 2017). Correspondingly, a tro-
ponin raise is also secondary to myocardial ischemia and is elevated in 25% of 
ATAAD patients (Bonnefoy et al., 2005). Although neither ECG nor troponin are 
diagnostic for ATAAD, they are harbingers of poor outcomes in patients with 
ATAAD. 
In 2010, the ACC/AHA guidelines proposed a risk assessment scoring tool for 
assessing the probability of acute aortic syndrome based on three features: predis-
posing conditions, pain features and clinical examination (Table 2) (Hiratzka et al., 
2010). The scoring system was tested retrospectively using the IRAD database and 
stated as a highly sensitive clinical tool for detecting acute aortic dissection 
(Rogers et al., 2011). The key for diagnosing ATAAD is to keep it readily in mind 
and harbour a suspicion when patient is presented with one or more of the condi-
tions listed in table 2.  
Table 2. Risk assessment tool for detecting acute aortic dissection (Erbel et 
al., 2014). 
High-risk conditions High-risk pain features High-risk examination features 
Marfan syndrome (or other con-
nective tissue diseases) 
Chest, back, or abdominal pain  
described as any of the following: 
Evidence of perfusion deficit: 
 pulse deficit 
Family history of aortic disease  abrupt onset  systolic blood pressure difference 
Known aortic valve disease  severe intensity  focal neurological deficit (in conjunct- 
Known thoracic aortic aneurysm  ripping or tearing tion with pain) 
Previous aortic manipulation   Aortic diastolic murmur (new and with pain) 
(including cardiac surgery) Hypotension or shock 
2.5.4 Differential diagnosis of TADs 
Due to low incidence and diverse symptoms that often mimic other, more common 
disorders, such as myocardial ischemia or stroke, the diagnosis of ATAAD is often 
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delayed, mistaken or even missed (Luo et al., 2009). A prompt differential diag-
nosis between acute coronary syndrome and ATAAD is essential but can be very 
tricky. Sometimes congestive heart failure might be the only clinical finding and 
can be therefore often misleading. Moreover, it is not uncommon that these condi-
tions occur simultaneously, which makes it even more complicated. Other im-
portant differential diagnoses include pulmonary embolism, myopericarditis, 
pneumothorax or hemothorax, dyspepsia, pneumonia, pleuritis, esophagitis, oe-
sophageal spasm or perforation, ulcus perforation, Tieze’s syndrome, and other 
musculoskeletal syndromes (Spittell et al., 1993).  
2.6 Management of TADs 
2.6.1 General principles 
The only curative treatment for AscAA is surgery. The risks of complications, such 
as dissection or rupture, and possibly the progression of the aneurysm, however, 
can be reduced with medical therapy for the patients who do not yet meet the sur-
gical criteria or are not eligible for an open surgery (Chun et al., 2013). Beta-ad-
renergic receptor blockade is considered the cornerstone of medical treatment of 
AscAA. It reduces the heart rate, decreases systolic pressure and the stress on the 
aortic wall (Shores et al., 1994). Some promising results in preventing aortic en-
largement have been shown with angiotensin II receptor blocker in patients with 
Marfan syndrome (Brooke et al., 2008; Pees et al., 2013), however, larger clinical 
trials are still on the way (Mullen et al., 2013; Pitcher et al., 2015). Statins may 
also have beneficial effects against complications (Jovin et al., 2012). In terms of 
lifestyle, patients with TAD should also be cautious with intense, strenuous iso-
metric activities (Hatzaras et al., 2007), avoid cocaine and other powerful stimu-
lants, and quit smoking (Goldﬁnger et al., 2014). 
The standard treatment for ATAAD is an immediate open cardiac surgery (Sutton 
et al., 1981). However, lowering blood pressure in the acute setting may limit the 
expansion of the dissection and thus likely reduces the extent of the disease, al-
lowing more time for surgery (Kaji, 2019). 
26
31157481_Vaitoskirja_Emily_Pan_Laaketiet_tdk_sisus_B5_2606.indd   26 26.6.2019   9.12
28 Review of literature 
2.6.2 Surgical repair 
2.6.2.1 Indications for surgical repair of TADs 
Every patient presenting with ATAAD should be considered for surgery. There are 
few absolute contraindications for surgery, namely a background of terminal ill-
ness, global irreversible cerebral ischemia, and the patient’s wish. Poor neurolog-
ical response, coma, cardiogenic shock secondary to severe malperfusion are more 
relative and are at the discretion of the operating surgeon considering the patient’s 
individual risk profile, life-expectancy and expectations. 
Both the European (ESC) and the American (ACCF/AHA) guidelines on aortic 
diseases recommend elective surgery for AscAA when the maximal aortic diame-
ter is ≥ 55 mm, regardless of aetiology, and when the aneurysm is symptomatic 
(class IIaC in ESC, class IC in ACCF/AHA) (Erbel et al., 2014; Hiratzka et al., 
2010). Both guidelines also recommend a consideration for a concomitant repair 
of the aortic root or ascending aorta replacement with a size ≥ 45 mm when the 
patient is undergoing an open aortic valve repair or replacement, particularly if the 
valve is bicuspid (class IIaC in both ESC and ACC/AHA) (Erbel et al., 2014; 
Hiratzka et al., 2016).  
According to ESC Guidelines on the diagnosis and treatment of aortic diseases 
(Erbel et al., 2014), patients with Marfan syndrome should have a lower threshold 
of ≥ 50 mm for aortic surgery (class IC). Marfan patients with additional risk fac-
tors including a family history of dissection, a size increase of > 3 mm/year on 
repeated examinations, severe aortic or mitral regurgitation, or the desire to be-
come pregnant, the surgery should be considered already when the aortic diameter 
reaches ≥ 45 mm (class IIaC). There is not enough data available regarding patients 
with other connective tissue diseases. It is, however, generally recommended to 
treat them as Marfan patients but since patients with Loeyz-Diez syndrome or con-
firmed TGFBR1 or TGFBR2 mutation have higher risks for aortic complications, 
ESC guidelines proposed an intervention when aortic diameter reached > 42 mm 
(class IIaC). For patients with BAV, both ESC and ACCF/AHA guidelines recom-
mend surgery when aortic diameter exceeds ≥ 55 mm (class IB in ACC/AHA, class 
IIaC in ESC), but 50 mm can be considered when there are additional risk factors, 
such as family history, systemic hypertension, coarctation of the aorta, or aortic 
diameter increase of > 3 mm / year according to ESC (class IIaC) and ≥ 5 mm/ 
year in an aorta that is < 55 mm in size according to ACC/AHA (class IIaB) in 
repeated examinations (class IIaB) (Erbel et al., 2014; Hiratzka et al., 2016).  
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Figure 4.  A photograph from an ATAAD operation showing a dissected aorta 
with a direct visibility to the primary tear site. The ascending aorta 
has been resected. Published with permission of the copyright 
holder, Professor Tomas Gudbjarttson. 
2.6.2.2 Principles of surgical techniques 
The goal of surgical intervention is to prevent further lethal complications, and to 
ensure adequate systemic perfusion by re-establishing blood flow to the true lumen 
of the aorta in the case of a dissection (El-Hamamsy et al., 2016). 
Contemporary TAD surgery consists of standard median sternotomy and pericar-
diotomy, then arterial cannulation for initiating cardiopulmonary bypass (CPB). 
There are three major aortic cannulation strategies for CPB; through axillary or 
subclavian artery, using femoral artery, or direct aortic cannulation (Paulis et al., 
2015). Less frequently used cannulation strategies include transapical cannulation 
and transatrial left ventricular cannulation through the right upper pulmonary vein 
(Schoeneich et al., 2015). The extent of the surgery, the accessibility and dissection 
of the cannulation site affect the decision on which site to choose.  
Axillary artery or subclavian artery cannulation with a separate end-to-side anas-
tomosed 6- or 8-mm Dacron graft is nowadays commonly used. This technique is 
time-consuming compared to other techniques but it provides antegrade perfusion, 
an easy accessibility for cerebral perfusion under hypothermic circulatory arrest 
(HCA), and has been proved safe (Rylski et al., 2016). Animal studies and retro-
spective studies have also suggested that axillary artery cannulation might reduce 
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embolic stroke events and thus early mortality (Etz et al., 2008; Hedayati et al., 
2004; Kim et al., 2019; Svensson et al., 2004).  
Direct aortic cannulation into the true lumen is fast and therefore preferred when 
rapid initiation of CPB is needed. However, it has gained popularity in other situ-
ations as well as it provides faster access for an antegrade cerebral perfusion and 
there is increasingly amount of evidence showing that direct central cannulation 
might be as safe as peripheral cannulation (Kreibich et al., 2018 Accepted 
manuscript; Frederick et al., 2013; Gegouskov et al., 2018; Reece et al., 2007). 
Typically, the cannulation site is located under the lesser curvature of the arch, and 
it is performed using the Seldinger technique under ultrasound guidance (Gobolos 
et al., 2008; Kitamura et al., 2017). The cannulation does not leave any damage to 
the aortic wall as the cannulation site can be resected while performing the aortic 
anastomosis.  
Femoral artery cannulation in TAD surgery has declined in popularity as it causes 
retrograde CPB perfusion, which may lead to inadequate flow distribution between 
true and false lumens, thus generating organ malperfusions, as well as possible 
retrograde embolization of atheromatous material (El-Hamamsy et al., 2016; 
Gulbins et al., 2007; Kim et al., 2019; Van Arsdell et al., 1998). There are no ran-
domized prospective trials regarding cannulation techniques, but many retrospec-
tive studies have shown lower in-hospital mortality and lower incidence of perma-
nent neurological deficit when using axillary artery cannulation compared to fem-
oral artery cannulation (Benedetto et al., 2015; Gulbins et al., 2007; Ren et al., 
2015).  
After the venous cannula is placed into the right atrium, the aorta is cross-clamped 
and CPB is initiated. The heart is then stopped with intermittent cardioplegia. The 
operation consists of resection of the primary tear, when distinguishable, and re-
placement of ascending aorta with a Dacron tube graft (Figure 4). If there is aortic 
regurgitation, the aortic valve can be repaired by resuspension of the native valve, 
or replaced either using a valve-sparing technique performed by a surgeon familiar 
with the procedure or with a prosthetic valve (Beckmann et al., 2017). More often 
when the valve is compromised, aortic root replacement with coronary artery im-
plantation, as well as aortic arch repair, when needed, will be carried out. Addi-
tional concomitant procedures like coronary artery bypass (CABG) or mitral valve 
repair (MVR) are also sometimes required.  
In most contemporary centres, the distal anastomosis is sutured without aortic 
clamping (open-distal anastomosis) under direct vision, to enable visualization of 
the distal aorta and adequate resection of the compromised segment of the aortic 
wall. An open distal anastomosis also ensures precise placement and thereby a high 
quality of sutures, and it appears to be associated with better outcomes than a 
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clamped-on anastomosis, although there are not many comparative studies on the 
subject (Geirsson et al., 2018; Malvindi et al., 2016). Open-distal anastomosis re-
quires discontinuing CPB, during which protection against organ ischemia is car-
ried out by cooling the body temperature and thus decreasing the oxygen demand 
for metabolism. This is called hypothermic circulatory arrest (HCA), which can be 
moderate (24-28℃) or deep (18-20℃). There is no unequivocal consensus on the 
optimal temperature, but the recent literature tends to favour moderate hypother-
mia as deeper hypothermia is counterbalanced by a higher propensity for bleeding 
complications due to coagulopathy associated with lower temperature (Algarni et 
al., 2014; Keeling et al., 2017; Sun et al., 2018). A separate cerebral perfusion can 
be established during HCA to prolong the tolerated ischemic window. An ante-
grade cerebral perfusion, either through the right axillary artery or bilaterally 
through the right axillary and left carotid arteries, is often used as it is likely to 
provide longer ischemic time, possibly better brain perfusion and less cerebral 
complications compared to retrograde perfusion (Abe & Usui, 2017; Panos et al., 
2006; Reuthebuch et al., 2004; Shimazaki et al., 2004). Alternatively, the supra-
aortic branches may be selectively cannulated for cerebral perfusion. Retrograde 
cerebral perfusion through the superior vena cava is also used in many centres but 
may be associated with worse neurological outcomes and a higher incidence of 
prolonged ICU stay compared to antegrade cerebral perfusion, although there are 
studies demonstrating excellent outcomes with both techniques (Griepp et al., 
1997; Okita et al., 2015; Spielvogel et al., 2013; Sugiura et al., 2012; Ueda et al., 
1999).   
2.6.2.2.1 Supracoronary aortic replacement 
Isolated supracoronary aortic replacement typically means the ascending aorta be-
tween the coronary ostia and the brachiocephalic artery is resected and replaced 
with a vascular tube graft (Figure 5a). It is considered the “simplest” technique for 
both AscAA and ATAAD repair when the ascending aorta is affected without sig-
nificant aortic root involvement and the valve is competent and not stenotic. How-
ever, more often TAD is associated with aortic valve disease as well (David et al., 
2007). The decision to undertake supracoronary replacement alone is often a com-
promise when seeking to avert the increased risk of perioperative morbidity asso-
ciated with more extensive repair, for example in a patient deemed to poorly tol-
erate extended operative and CPB durations, especially in ATAAD surgeries.  
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2.6.2.2.2 Aortic root surgery 
Aortic root is often affected in TAD diseases. In ascending aortic aneurysms, the 
sinuses and the sinotubular junction area are often dilated, especially in patients 
with Marfan. In ATAAD with primary intimal tear located in the ascending aorta, 
the dissection often extends into the non-coronary sinus, less frequently into the 
left or right coronary sinus, causing aortic regurgitation.  
Most of the time, even when the aortic valve is partially dissected, the native valve 
can be repaired and competency restored without replacement (Leshnower & 
Chen, 2016). Aortic root can be repaired with resuspension of the aortic valve by 
suturing from its three commissures. The “sandwich” technique – Teflon felt with 
or without biological glue is placed between the dissected layers of sinuses to sup-
port the media layer – may be applied (Rylski et al, 2014). If the aortic valve needs 
to be replaced, both ESC guidelines on valvular diseases and ACCF/AHA guide-
lines on thoracic aortic disease generally recommend valve-sparing procedures 
performed by experienced surgeons when technically feasible, and if not, aortic 
root replacement using a composite graft conduit prosthesis (Baumgartner et al., 
2017; Hiratzka et al., 2016). A valve-sparing procedure is recommended in patients 
with aortic root dilation and tricuspid aortic valves according to ESC (class IC), 
and also in patients with aortic root dilation and valve regurgitation according to 
ACCF/AHA (class IC), provided that the surgeon is experienced in the technique. 
Patients with Marfan syndrome or other connective tissue disease undergoing an 
aortic surgery are typically younger and, therefore, a valve-sparing technique is 
particularly appealing. If the aortic root is severely dilated (≥ 45 mm) or dissected, 
if the patient has a concomitant severe aortic valve disease, such as valvular ste-
nosis, or has a history of a connective tissue disease, a valve-sparing root replace-
ment or replacement with a mechanical or biological valve should be indicated 
(Leshnower & Chen, 2016). 
The Bentall-de Bono procedure was first described in 1968 and has since been 
referred to as the golden standard for aortic root repair. The original Bentall and 
de Bono technique involves a tubular composite graft including a mechanical valve 
which is sutured to the aortic annulus and distal aorta. The coronary arteries are 
reimplanted into the graft and the aneurysm wall is not removed but wrapped 
tightly around the graft for hemostasis (Bentall & De Bono, 1968). This technique 
is associated with high coronary complications, such as coronary detachment, post-
operative bleeding, and recurrent pseudoaneurysm formation at the coronary artery 
and around aortic anastomoses (Crosby et al., 1973; Inberg et al., 1985; 
Kouchoukos & Marshall, 1986). There were various modifications introduced to 
reduce these complications. Cabrol et al described a technique where the coronar-
ies are sutured end-to-end to a separate small graft which is then anastomosed to 
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the aortic graft (Cabrol et al., 1981). This technique showed worse outcome com-
pared to direct reimplantation and therefore has not been adapted. Inberg et al. 
from Turku University Hospital presented a modified root repair with a composite 
graft in 1985 (Inberg et al., 1985). In their technique, the aneurysm is entirely re-
sected, and both the coronary ostia and the proximal parts of the coronary arteries 
were dissected free and mobilized before reimplantation to the graft, which reduces 
tension at the coronary anastomosis. This technique is similar to what has been 
later popularized by Kouchoukos and associates, who dissected the coronaries with 
a button of aortic tissue, known as the coronary button technique (Kouchoukos et 
al., 1991). Nowadays, in a typical modified Bentall procedure the aneurysm sack 
is resected and a composite Dacron graft containing either a mechanical or a bio-
prosthetic valve replaces the diseased valve and ascending aorta, and the coronary 
arteries are detached from the aortic sinuses and sutured to the graft using a button-
technique (Figure 5b). The Bentall procedure using a composite graft shows ex-
cellent durability and low mortality, and the long-term results are excellent 
(Celiento et al., 2016; Ehrlich et al., 2001; Mookhoek et al., 2016; Nezafati et al., 
2015).  However, due to many adverse effects related to an artificial valve, such as 
life-long anticoagulation and increased risk of endocarditis and aortic stenosis, the 
native valve is preferably preserved whenever possible. 
The first valve-sparing technique, known as Yacoub’s procedure, was introduced 
by Sir Magdi Yacoub in the late 1980s (Yacoub et al., 2018). This procedure re-
constructs the aortic root with remodelling technique, which means the graft is 
tailored to conform to the shape of aortic sinuses and the anastomoses is performed 
following the shape. However, this technique does not protect the annulus from 
the dilation (Rahnavardi et al., 2011). 
Another valve-sparing technique, the David procedure, has become more and more 
common in recent years. In the David reimplantation procedure, introduced by Dr. 
Tirone David in 1992, the aortic sinus segments are excised leaving a 2-3 mm 
remnant of aortic tissue around the annulus. The ascending aorta is then replaced 
with a tubular graft that is seated at the level of the aortic annulus. The aortic valves 
are reimplanted by pulling the commissures upwards and securing them to the graft 
using sutures (David & Feindel, 1992) (Figure 5b). If the valve has prolapsing 
cusps, they can be shortened by plication along the nodule of Arantius (David, 
2011). This technique protects and supports both the valve leaflets and the annulus, 
therefore conferring protection from subsequent dilatation (Beyersdorf & Rylski, 
2012).  
Although David’s procedure is time-consuming, the results from large centres us-
ing valve-sparing technique in elective cases are superb. In David’s procedure, the 
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results have shown excellent valve durability, low early and late mortalities, and 
low need for any reoperation (David et al., 2010; Paulis et al., 2010; Kallenbach et 
al., 2005; Leontyev et al., 2012; Svensson et al., 2013). The recurrence of severe 
aortic valve regurgitation, the need for a later reoperation, and the long-term mor-
tality seem to be lower when using David’s reimplantation technique compared to 
Yacoub’s remodelling technique (Kallenbach et al., 2013). Especially in patients 
with Marfan syndrome or other connective tissue disease, the aortic tissue is 
weaker and therefore the David’s technique is more justified, as it provides an extra 
fixation of the aortic annulus, whereas the Yacoub’s technique does not (Benedetto 
et al., 2011; Flynn et al., 2017; Price et al., 2016). 
2.6.2.2.3 Aortic arch repair 
When the aortic dissection extends to aortic arch and beyond, or if the primary tear 
is located in the aortic arch, the arch is likely to be repaired. ESC guideline recom-
mends aortic arch repair for patients with the maximal diameter of ≥ 55 mm or 
who present symptoms or signs of local compression (Erbel et al., 2014). The 
choice of operative technique depends on the clinical presentation and aortic anat-
omy of the patient, especially the size of the aorta and the location of the intimal 
tear, but not the least on the experience of the surgeon and the centre (El-Hamamsy 
et al., 2016). Most commonly used techniques are hemiarch replacement or total 
arch replacement with or without an intraluminal stent graft put into the proximal 
descending aorta (Poon et al., 2016b; Roselli et al., 2018; Shrestha et al., 2017).  
Hemiarch replacement is the simplest and quickest technique when the aortic arch 
is partially affected (Figure 5c). In hemiarch replacement, a various length of the 
lesser curvature of the aortic arch is resected obliquely but the branch vessels and 
the downstream aorta are untouched (Sultan et al., 2016). The prosthesis is fash-
ioned into a shape mimicking the aortic arch, and the distal anastomosis is then 
performed in an open-distal fashion under deep or moderate HCA preferably with 
selective cerebral perfusion. This technique mandates direct inspection of the distal 
aortic arch and the branch vessels.  
Total arch replacement is a more aggressive approach for repairing a diseased arch 
(Figure 5c). An extended arch surgery enables resection of primary intimal tear 
beyond the ascending aorta and possibly excludes re-entry tears in the distal aorta 
and expands the distal true lumen, potentially reducing postoperative malperfusion 
and later reinterventions (El-Hamamsy et al., 2016; Smith et al., 2017). In the total 
arch replacement, both the ascending aorta and the aortic arch are completely re-
sected, and the distal anastomosis extends distal to the left subclavian artery. The 
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supra-aortic vessels can be reimplanted as an island en bloc or each vessel sepa-
rately with or without a branched graft (Shelstad et al., 2016a). In the island tech-
nique, the supra-aortic vessels are resected as a single aortic patch. This technique 
limits the number of anastomoses and may be the fastest technique, but in 
ATAAD, the tear might be present around the greater curvature of the aorta, and 
the dissected tissue is often problematic as it’s fragile for sutures and potentially 
diseased aortic tissue remains after surgery. The technique is also difficult in reach-
ing the posterior anastomosis in the case of bleeding. A variation of the island 
technique is the peninsula technique described by Itoh et al. They suggested for 
arch replacement, specifically in patients with BAV and arch dilatation, an opera-
tion in which a cleft is formed in the distal part of the arch prosthesis, leaving the 
island of supra-aortic vessels connected with the distal native aorta, thereby creat-
ing a peninsula (Itoh et al., 2010). 
Kazui et al introduced a technique using an aortic arch graft that has three or four 
branches attached (Kazui et al., 2000). The branches of the graft were anastomosed 
to the brachiocephalic artery, the left common carotid artery and the left subclavian 
artery. The additional fourth branch is used for antegrade perfusion and will be 
later resected. Spielvogel et al developed a separate trifurcated graft in order to 
enable antegrade cerebral perfusion (Spielvogel et al., 2002). The graft serves itself 
as the brachiocephalic trunk and has two branch limbs which are anastomosed to 
the left common carotid artery and the left subclavian artery under the period of 
HCA while using a selective cerebral perfusion from the right axillary artery. The 
proximal prosthetic brachiocephalic trunk is then anastomosed graft-to-graft fash-
ion to the aortic arch prosthesis. There are many variations of branched techniques 
which all enable the resection of the origin of arch vessels as they most frequently 
develop atherosclerotic lesions, and the distal anastomosis can be performed at the 
intact sites of branch vessels. The perfusion time may be reduced, especially in the 
Spielvogel’s technique, when the corresponding branch may be opened after the 
previous branch anastomosis is performed.  
Total arch replacement is technically challenging, especially with branch grafts, 
and significantly increases risk of morbidity and mortality compared to less ag-
gressive procedures (Shelstad et al., 2016b). Therefore, it requires a great level of 
experience and expertise from the surgical team. The long-term outcomes are not 
well established, and there are mixed results based on retrospective studies 
(Preventza et al., 2015; Shi et al., 2014; Smith et al., 2017b). Unequivocal superi-
ority for a single technique is difficult to ascertain, as the results are dependent 
upon many factors, such as the specifics of the patient and his/her unique pathol-
ogy, as well as the experience of the surgical team in different approaches.  
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2.6.2.2.4 Endovascular treatment 
The first successful endovascular repair of ATAAD was reported in 2000 (Dorros 
et al., 2000). Since then, endovascular technology has made leaps forward in the 
management of the aortic valve and the descending aorta, but the progress has not 
been significant for ascending aortic diseases. The reasons lie in the complexity of 
regional anatomy, technical difficulties and high complication rates. Nevertheless, 
endovascular techniques for ATAAD have been under active scrutiny, and a few 
small studies have shown appropriate results in carefully selected patients 
(Bernardes et al., 2014; Follis et al., 2016; Horton et al., 2016; Ronchey et al., 
2013). Further research is warranted before endovascular techniques can be imple-
mented in clinical use.  
The frozen elephant trunk technique (FET) was first introduced in 1996 by Kato 
et al. (Kato et al., 1996), and it has undergone many modifications since then. FET 
is a hybrid technique that combines conventional ascending aortic surgery with an 
endovascular stentgraft that is placed in the proximal descending aorta and anas-
tomosed to the aorta reminiscing an elephant’s trunk, hence the name (Roselli et 
al., 2018). In ATAAD, when there is type I DeBakey dissection or aneurysm that 
involves descending aorta, the FET technique is thought to reduce later complica-
tions from the remaining dissection or aneurysm, as it helps to expand the true 
lumen in the proximal descending aorta and consequently reduces the false lumen, 
thereby promoting its thrombosis (Shrestha et al., 2015). The FET technique, how-
ever, is a complex procedure with long CPB time, and it is thought to be associated 
with a higher risk of postoperative complications, especially spinal injuries 
(Shrestha et al., 2015). However, in complex thoracic aortic pathologies, the results 
in the centres that have adopted this technique have been promising (Koizumi et 
al., 2018; Lin et al., 2015; Shrestha et al., 2015; Sun et al., 2011). 
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Figure 5b.  Aortic root repair: Bentall’s procedure on the left and valve-sparing 
technique with coronary artery implantation, also known as David’s 
procedure, on the right.  
 
Figure 5c.  Ascending aortic repair involving arch: hemiarch replacement on the 
left and total arch replacement using separate branch grafts on the 
right.  
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2.7 Outcomes after ascending aortic surgery 
In unruptured TAD surgeries, the 30-day mortality varies between 3.8-7.6% 
(Achneck et al., 2007; Higgins et al., 2014; Olsson et al., 2006). Stroke is the most 
feared complication and 5.8% were reported to suffer from perioperative stroke 
(Achneck et al., 2007). A large American registry-based study that included all 
types of thoracic aortic surgeries reported a perioperative mortality (in-hospital or 
30-day) of 8.67% for isolated ascending aortic replacement, 11.7% when the arch 
is involved and 7.6% when both the root and the arch were involved (Williams et 
al., 2012).  
Hospital survival after ATAAD surgery is mostly related to patient’s preoperative 
conditions and the worst results are reported in patients with cardiogenic shock, 
cardiac tamponade, cardiac arrest, and end-organ malperfusions, especially mes-
enteric malperfusion. The initial mortality rate varies a great deal between different 
studies and settings. In some high-volume single centres, the 30-day mortality was 
reported as low as 5% (Shi et al., 2014; Sun et al., 2011) but in most cases, the in-
hospital or 30-day mortality were reported between 15.6% and 21% (Colli et al., 
2016; Estrera et al., 2015; Narayan et al., 2008; Yeh et al., 2015). Large population 
studies have typically reported higher mortality rates; some as high as 37-45% for 
30-day mortality (Howard et al., 2013; Olsson et al., 2006).  On the other hand, 
these studies have unselected patient flow and may thus better represent of real-
life situations. Two largest ATAAD registries, GERAADA and IRAD, have a 30-
day mortality of 16.9% and an in-hospital mortality of 23.8%, respectively 
(Conzelmann et al., 2016; Trimarchi et al., 2010). The surgical mortality has 
dropped from 25% to 18% in two decades (Evangelista et al., 2018). Among pa-
tients discharged from the hospital, the estimated long-term survival at 1, 5, 10 and 
20 years varies between 90.7%, 71.8-73%, 53.0-67.5% and 24.0% respectively 
(Bekkers et al., 2012; Concistre et al., 2012; Endlich et al., 2016; Geirsson et al., 
2007; Wang et al., 2014).  
Most frequent major complications after ATAAD surgery are bleeding problems, 
permanent neurological dysfunction, and organ failures. Bleeding leading to a rest-
ernotomy occurs in 19% (Olsson & Franco-Cereceda, 2013). During hospitaliza-
tion, major brain injury occurs in approximately 7%, acute kidney failure in 17%, 
new myocardial infarction in 6% and cardiac tamponade in 5% (Eusanio et al., 
2013). However, it is hard to differentiate to what extend the complication was 
developed postoperatively instead of being already present before the surgery.  
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There is scarce information in the literature regarding patients with ATAAD and 
preoperative cardiac arrest. However, preoperative CPB is a well-known inde-
pendent risk factors for early mortality (Bekkers et al., 2012; Chiappini et al., 2005; 
Conzelmann et al., 2016; Hata et al., 2010). Other risk factors for in-hospital mor-
tality include preoperative organ malperfusion, coma, cerebrovascular accident, 
hypotensive shock at presentation, ischemic peripheral neuropathy, and prior car-
diac surgery (Trimarchi et al., 2010; Tsai et al., 2006). Longer CPB and HCA time 
were also associated with higher mortality (Bekkers et al., 2012; Hata et al., 2010; 
Tan et al., 2003). 
The most common indications for a reoperation after ATAAD surgery are pseudo-
aneurysms that typically develop adjunct to suture lines (Kobuch et al., 2012). 
Freedom from proximal reoperation has been reported at 94.6%, 76.8-91.5%, and 
79.3% at 5, 10, and 20 years, respectively, and 87.6%, 76.4-93.4%, and 83.3% at 
5, 10, and 20 years from distal reoperation, respectively (Geirsson et al., 2007; 
Wang et al., 2014).  
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3 AIMS OF THE STUDY 
The purpose of the study is to use large, comprehensive data registries to provide 
better understanding of thoracic aortic diseases and portray real-life outcomes after 
ascending aortic surgeries in a perspective of a single centre as well as in a multi-
national setting. In more detail, the aims are: 
1. To describe the incidence and long-term outcomes after ascending aortic 
surgery in Southwest Finland during four decades; 
2. To depict the incidence of reoperations after ATAAD surgery and to eval-
uate the relationship between the extent of primary aortic repair and its im-
pact on later reoperations;  
3. To evaluate outcomes after ATAAD surgery in patients with preoperative 
cardiac arrest. 
Aims of the study40
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4 MATERIALS AND METHODS 
4.1 Study design and populations 
4.1.1 Study I 
The study cohort consists of 614 consecutive patients that underwent primary as-
cending aortic surgery in Turku University Hospital, Southwest Finland, between 
1968 and 2014. Baseline data were retrospectively collected from patient records 
and surgical logs. Mortality data were obtained from Statistics Finland. For sur-
vival analysis, only patients surviving the index surgery were included. One patient 
was lost during follow-up. 
Population data for incidence calculations were also retrieved from Statistics Fin-
land. Patients ≥ 18 years were included, and the incidence calculation was stand-
ardized using the 2000 US Standard population with direct method. The current 
geographical catchment area for Turku University Hospital was established in 
1984, therefore years 1984-2014 were used in the incidence calculation study. 
To evaluate the impact of eras, the surgeries were categorized into four eras: 1968-
1980, 1981-1990, 1991-2000, and 2001-2014. The characteristics of the popula-
tion and surgical procedures were compared between the eras. Age was divided 
into five categories: ≤ 40, 41–50, 51–60, 61–70 and > 70 years. Surgical proce-
dures were grouped as following: isolated supracoronary ascending aortic replace-
ment, modified Bentall procedure (a composite graft with a mechanical or biolog-
ical prosthetic valve and separately implanted coronary arteries), Bentall procedure 
with concomitant CABG or MVR, valve-sparing procedure (David or Yacoub pro-
cedure), hemiarch repair, or total arch repair. The indication for surgery was di-
vided into two groups: 1) acute or chronic ascending aortic dissection, aortic rup-
ture or intramural haematoma, and 2) elective indications, such as thoracic aortic 
aneurysms.  
4.1.2 The Nordic Consortium for Acute Type A Aortic Dissection -registry 
Collaborations between eight Nordic tertiary cardiothoracic centres resulted in a 
joint database, the Nordic Consortium for Acute type A Aortic Dissection (NOR-
CAAD), to study acute type A aortic dissection (Geirsson et al., 2016). The centres 
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involved were Aarhus University Hospital, Skejby, Denmark; Karolinska Univer-
sity Hospital, Stockholm, Sweden; Landspitali University Hospital, Reykjavik, 
Iceland; Sahlgrenska University Hospital, Gothenburg, Sweden; Skåne University 
Hospital, Lund, Sweden; Tampere University Hospital, Tampere, Finland; Turku 
University Hospital, Turku, Finland, and Örebro University Hospital, Örebro, 
Sweden. The population catchment area for NORCAAD is estimated at 9,500,000. 
The database consists of 1,159 consecutive surgically treated patients with 
ATAAD between January 1st, 2005, and December 31st, 2014, in the participating 
centres. The operation had to be performed within two weeks from the diagnosis 
or the first symptoms. The database was retrospectively collected from hospital 
records and mortality data obtained from each country’s national population reg-
istries. Each centre was responsible for its own data collection.  
A total of 194 variables were collected including demographics, past medical his-
tory, preoperative medications, clinical symptoms at presentation, diagnostic 
methods, operative variables, postoperative complications, bleeding and blood 
transfusions, laboratory test results, outcomes, follow-up echocardiography data, 
and reoperation data. 
4.1.2.1 Study II 
For study II, additional variables regarding reoperations (indications, urgency, date 
and type of surgery, and cause of death) were requested, and the information was 
collected retrospectively from patient logs of each centre. The data regarding the 
extent of primary surgery and/or reoperations was incomplete in 28 patients that 
were therefore excluded, leaving 1,131 cases for analysis.  
Primary endpoints in the study were either reoperation or death. Reoperation was 
defined as any cardiac or aortic surgery that could be related to primary ATAAD 
surgery. Reoperations due to bleeding were excluded as they represent periopera-
tive complications instead of directly reflecting the impact of different types of 
surgical approaches.  
Each primary ATAAD repair and each reoperation procedure were classified ac-
cording to both 1) proximal repair that is divided to either isolated supracoronary 
replacement group or aortic root group if the surgery included concomitant root 
replacement or valve-sparing procedure, and 2) the location of distal anastomosis 
that is further divided into ascending aorta, hemiarch, or total arch groups. Due to 
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low volume of both hemiarch and total arch groups, these two groups were com-
bined for competing risk survival analysis. The patient selection and groups are 
presented in the flow chart (Figure 6). 
Figure 6. Flow chart of patient selection and types of primary ATAAD sur-
gery   in Study II. 
4.1.2.2 Study III  
In study III, 1,154 cases were included for analysis as 5 patients were excluded 
due to missing detailed information on preoperative cardiac arrest. Additional de-
tails regarding preoperative cardiac arrest and these patients’ later daily functional 
ability were individually collected from each participating centre.  
Preoperative cardiac arrest was defined as circulatory collapse that required a pe-
riod of cardiopulmonary resuscitation (CPR) within 24 hours prior to ATAAD sur-
gery. The location of cardiac arrest was divided into out-of-hospital, at the refer-
ring hospital, at the operating hospital, or in the operating room, and defined as the 
location when the first episode occurred. Unstable hemodynamics in the operating 
room was classified as systolic blood pressure < 90 mmHg, ventricular arrhythmia. 
or ongoing cardiac arrest. 
Patients with preoperative cardiac arrest were compared with those who did not 
experience preoperative arrest. In addition, survivors and non-survivors in the pre-
operative cardiac arrest group were compared. (Figure 7) 
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Figure 7 Flow chart of patient selection for Study III. 
4.2 Ethical considerations  
Study I was approved by the local institutional review board of Southwest Finland 
Hospital District, and a waiver of informed consent was granted due to the retro-
spective nature of the study. 
In the NORCAAD studies, the study subjects were given randomly an identifica-
tion number, and all potential patient identifiers were blinded. Each centre ob-
tained approval from their data protection committees or commissions. As in Study 
I, individual patient consent was not needed in the NORCAAD studies, given the 
retrospective registry-based nature. 
4.3 Statistical analyses 
4.3.1 Study I 
All statistical analyses were performed with SPSS IBM Statistics version 22.0 
(IBM, Armonk, NY, USA). Chi-squared test was used to compare categorical var-
iables and Mann-Whitney U-test was used for continuous variables. Kaplan-Meier 
survival curves were used to depict long-term survival for 30-day survivors, and 
the groups were compared using log-rank test. Clinically relevant variables were 
chosen for Cox proportional hazard regression analysis. First, the univariable Cox 
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regression analysis was used, and then the same variables were included in multi-
variable Cox regression analysis to identify predisposing factors for mortality. 
Hazard ratio (HR) was reported with 95% confidence interval, and p-value < 0.05 
was considered statistically significant. 
4.3.2 Study II 
IBM SPSS Statistics version 24 (IBM-SPSS Inc, Armonk, NY) was used for base-
line analyses. Continuous variables were reported as mean  standard deviation. 
Chi-square test was used to compare categorical variables between the groups. All 
tests were two-sided. Stata/IC15.0 for Windows (StataCorp, College Station, Tex) 
was used to perform the following analyses: a cumulative survival, a cumulative 
incidence, and Fine-Gray competing risk regression analyses. The reoperation in-
cidence curves after ATAAD surgery were stratified by the classification of 
DeBakey and the type of surgery (ascending aorta or arch involvement). These 
groups were then compared using Pepe-Mori test with death as a competing risk 
event. Fine-Gray competing risk regression model was used to identify independ-
ent risk factors for reoperation. The model was adjusted for connective tissue dis-
ease and DeBekey classification, and both types of proximal surgeries (supracor-
onary repair or aortic valve inclusive) and the types of distal anastomosis (ascend-
ing aorta, hemiarch, or total arch) were entered into the regression model. HR was 
reported with 95% confidence interval, and p-value < 0.05 was considered statis-
tically significant. 
4.3.3 Study III 
The statistical analyses were performed using IBM SPSS Statistics version 25 
(IBM, Armonk, NY, USA). For comparisons between non-ordered categorical var-
iables Chi-squared test was used, and between dichotomous variables Fisher’s ex-
act test was used. Continuous variables were reported as median with interquartile 
range (IQR). Mann-Whitney U-test was used to compare continuous variables. Lo-
gistic regression and univariable Cox regression analysis were performed to iden-
tify predisposing factors for overall mortality. Both odds ratios (OR) and HR were 
reported with 95% confidence interval. The proportional hazard was found satis-
fied in both groups for the time period of the events by visually reviewing the log(-
log(Survival)) vs log(time) figures. Kaplan-Meyer survival curves were used to 
depict mid-term survival, and log-rank test was used to detect statistical differences 
between the groups. P-value < 0.05 were considered statistically significant. All 
tests were two-sided.  
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5 RESULTS 
5.1 The operative incidence and characteristics of ascending aortic 
surgeries (Study I, II, III) 
The population calculation study showed that the incidence of surgically treated 
TADs was 1.68/100,000 inhabitants/year in 1984-1990 and 4.80/100,000 inhabit-
ants/year in 2011-2014. During the last decade, 2010-2014, the incidence was 
7.76/100,000 inhabitants/year for males and 1.95/100,000 inhabitants/year for fe-
males.  
The number of surgically treated TADs increased steadily in both sexes. Figure 8 
shows an average of 3.8 operations per year in 1968-1990 and 32.5 operations per 
year in 2010s. Male gender was over-represented throughout the time (n=491, 80% 
vs n=123, 20%, P < 0.001) but females tended to have proportionally more dissec-
tions and ruptures (n=51, 41.8% vs n=155, 31.7%; P = 0.04). 
Figure 8. Number of surgically treated ascending aortic diseases per decade. 
Reproduced from the original publication I with the permission of 
the copyright holders. 
Table 3 shows the evolution of patient selection and surgical procedures over time. 
Average age at the time of surgery was 56.0 ± 14.4 years. There were significant 
changes in the distribution of age over the study period. The proportion of younger 
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patients decreased significantly, and correspondingly, the proportion of elderly pa-
tients increased. The first patient above 70 years old was operated in the 90’s and 
within two decades, the proportion of ≥ 70 years olds grew into more than 25% of 
all operated patients.  
Table 3. Baseline characteristics and types of surgery stratified by time of 
ascending aortic surgery. Modified from the original publication I. 
Variable 1968-1980 1981-1990 1991-2000 2001-2010 2011-2014 Total P-value 
Sex        0.259 
   male 36 (72.0%) 72 (83.7%) 112 (84.8%) 169 (78.2%) 102 (78.5%) 491 (80.0%)  
   female 14 (28.0%) 14 (16.3%) 20 (15.2%) 47 (21.8%) 28 (21.5%) 123 (20.0%)  
Age       < 0.001 
   ≤ 40 24 (48.0%) 25 (29.1%) 18 (13.6%) 9 (4.2%) 13 (10.0%) 89 (14.5%)  
   41-50 7 (14.0%) 16 (18.6%) 28 (21.2%) 25 (11.6%) 9 (6.9%) 85 (13.8%)  
   51-60 13 (26.0%) 28 (32.6%) 40 (30.3%) 57 (26.4%) 32 (24.6%) 170 (27.7%)  
   61-70 6 (12.0%) 17 (19.8%) 39 (29.5%) 77 (35.6%) 43 (33.1%) 182 (29.6%)  
    ≥ 70 0 (0.0%) 0 (0.0%) 7 (5.3%) 48 (22.2%) 33 (25.4%) 88 (14.3%)  
Number of  
operations  
49 (8.0%) 87 (14.2%) 132 (21.5%) 216 (35.2%) 130 (21.2%) 614 (100%)  
Indication       0.003 
  Dissection/ 
  rupture 
8 (16.3%) 34 (38.4%) 55 (42.3%) 77 (35.6%) 343(25.4%) 207 (33.7%)  
  Others  
  (aneurysms) 
41 (83.7%) 53 (61.6%)
  
75 (57.7%)
  
139 (64.4%) 97 (74.6%) 404 (66.3%)  
Procedure       < 0.001 
  Bentall 22 (44.0%) 57 (66.3%) 70 (53.0%) 144 (66.7%) 74 (56.9%) 367 (59.8%)  
  Valve-sparing 0 (0.0%) 0 (0.0%) 0 (0.0%) 5 (2.3%) 14 (10.8%) 19 (3.1%)  
  Interposition 26 (52.0%) 21 (24.4%) 36 (29.5%) 20 (9.3%) 19 (14.6%) 122 (19.9%)  
  Arch repair 1 (2.0%) 3 (3.5%) 6 (4.5%) 24 (11.1%) 10 (7.7%) 44 (7.2%)  
  Bentall +    
CABG/MVR 
1 (2.0%) 5 (5.8%) 20 (15.2%) 23 (10.6%) 13 (10.0) 62 (10.1%)  
Reoperation 
due to bleeding 
0 5 1 13 1 20  
CABG = coronary artery bypass grafting; MVR = mitral valve repair 
Two-third of the operations were elective procedures, mainly ascending aortic an-
eurysms. The rest (33.7%) were ATAADs or ruptures. The modified Bentall pro-
cedure was the most frequently used approach almost throughout the study period, 
in average of 59.8% of all surgeries.  
In the NORCAAD database that included only surgically treated ATAADs, the 
mean age at the time of operation was 61.6  12.1 years, and 66.9% of the patients 
were male. The details of patient characteristics are summarized in Table 4. Types 
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and distribution of primary ATAAD surgeries are illustrated in Figure 6. Connec-
tive tissue disease (9.9% vs. 3.0%; P < 0.01) and bicuspid aortic valve (14.8% vs. 
3.0%; P < 0.01) were significantly more often present in the root repaired group, 
while open distal anastomosis technique was less used in comparison to supracor-
onary group. (95.4% vs. 88.3%; P < 0.01).  
Table 4.  Characteristics of patients with surgically treated ATAAD from the 
NORCAAD registry. (Studies II and III) 
Variables N Median  IQR / N 
(%) 
Age 1159 61.6 (54.0-70.7) 
Male gender 1159 784 (67.6%) 
Active smoking 1091 259 (22.3%) 
Family history of   
Aortic dissection 835   64 (5.5%) 
Thoracic aortic aneurysm 835 40 (3.5%) 
Clinical background   
Bicuspid aortic valve 1147 69 (6.0%) 
Connective tissue disease 1099 56 (4.8%) 
Marfan syndrome 1155 49 (4.2%) 
Known thoracic aortic aneurysm 1154 111 (9.6%) 
Previous cardiac or aortic surgery  64 (5.5%) 
Coronary artery disease 1159 48 (4.2%) 
Hypertension 1157 599 (51.7%) 
Chronic obstructive pulmonary disease 1155 69 (6.0%) 
Initial presentation   
Sudden pain 1152 981 (84.6%) 
Hypotensive shock 1073 254 (21.9%) 
Extent of Dissection 1151  
DeBakey Type I  842 (73.0%) 
DeBakey Type II  304 (26.3%) 
Organ malperfusion   
Cardiac malperfusion 1029 89 (7.7%) 
Cerebral malperfusion 1031 90 (7.8%) 
Gastrointestinal malperfusion 1030 35 (3.1%) 
Penn classification* 1049  
Class A  709 (23.4%) 
Class B  246 (21.2%) 
Class C  126 (10.9%) 
Preoperative lactate in serum (mmol/l) 628 1.6 (1.0-2.7) 
Pericardial tamponade 911 222 (24.4%) 
IQR = interquartile range; Penn Class A = no ischemia, Class B = localized 
ischemia, Class C = generalized ischemia 
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5.2 Outcomes after ascending aortic surgery (Study I, II, III) 
The median follow-up time in study I was 11.8 years (range 0-46.8 years). In this 
study, intraoperative mortality was 7.5% and 30-day mortality 16.0% for the entire 
cohort. Among those who survived the operation, the postoperative 30-day mor-
tality was 9.2% for all TADs, 18.3% for ATAADs or ruptures and 5.5% for other 
indications (P < 0.001).  
The cumulative survival for those who survived the index operation was 86.8%, 
79.5%, 70.3%, 47.1%, 34.6%, and 24.2% at 1, 5, 10, 20, 30, and 40 years, respec-
tively. After the first 30 days, the Kaplan-Meier analysis showed no statistically 
significant difference in long-term survival between emergent dissection/rupture 
group and electively operated group (P=0.096) (Figure 9).  
 
 
Figure 9. The cumulative survival after ascending aortic surgery in 30-day 
survivors, stratified by aneurysm and dissection/rupture groups. No 
statistically significant difference was detected (P=0.096). Repro-
duced from the original publication I with the permission of the 
copyright holders. 
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In NORCAAD studies, the mean follow-up time was 3.3 years (median 2.7, IQR 
0.5-5.5) in overall and 4.0 years (median 3.8, IQR 1.6-6.1) for 30-day survivors. 
For the entire cohort (n=1159), the intraoperative death occurred in 7.4%, hospital 
mortality rate was 15.9% and 30-day mortality 17.6%. Estimated survival at 1, 5 
and 8 years were 79.0%, 72.0% and 64.4%, respectively. For operative survivors, 
the estimated survival was 95.4%, 86.4%, and 76.5%, respectively. 
The survival rates from different sub-groups are summarized in table 5. 
Table 5. Cumulative survival after ascending aortic surgery in different sub-
groups. 
Variables N 1 year 3 years 5 years 10 years 20 years 
Elective ascending aortic surgery 405 87.2% 87.2% 82.0 75.0 51.6% 
ATAAD in a single centre 208 60.0% 57.4% 56.2 46.6% 29.4% 
ATAAD in NORCAAD 1159 79.7% 76.1% 72.1%   
Patients with preoperative cardiac ar-
rest 
44 49.2% 49.2%    
Patients that were reoperated* 51 96.0 93.4% 90.2%   
*bleeding reoperations were excluded 
 
5.3 Predictors of mortality after ascending aortic surgery (Study I, 
II) 
In study I, the results of the multivariable Cox proportional hazard analysis are 
shown in Table 6. Increasing age was an independent risk factor for both 30-day 
and long-term mortality. ATAAD or rupture were associated with 4-fold, and the 
earliest era of TAD surgery compared to the latest era predicted 6-fold higher risk 
of 30-day mortality (1968-1980 vs. 2010-2014, HR 6.0, P = 0.002). Aortic arch 
involvement, aortic root repair and other concomitant procedures (CABG/MVR) 
did not have a significant impact on long-term mortality for 30-day survivors com-
pared to isolated ascending aortic replacement procedures.   
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Table 6. Mortality assessed with multivariable Cox proportional hazard 
analyses after ascending aortic surgery. Modified from the original 
publication I. 
 
 
30-day mortality  Long-term mortality for  
30-day survivors 
 HR (95.0% CI) P-value HR (95.0% CI) P-value 
Sex (male vs. female) 0.97 (0.49-1.92) 0.93 1.23 (0.81-1.86) 0.327 
Age (per one year) 1.05 (1.02-1.08) 0.002 1.05 (1.03-1.06) 0.000 
Indication* 3.95 (2.16-7.23) <0.001 1.16 (0.80-1.68) 0.442 
Era (vs. 2011-2014)  0.002   
   1968-1980 6.00 (1.60-22.53) 0.008 2.16 (0.83-5.59) 0.113 
   1981-1990 0.89 (0.23-3.46) 0.870 1.58 (0.66-3.82) 0.306 
   1991-2000 0.37 (0.10-1.41) 0.147 1.37 (0.58-3.21) 0472 
   2001-2010 1.90 (0.90-4.01) 0.094 1.12 (0.48-2.63) 0.786 
Surgical approach (in addition to ascending aortic replacement)   
   +Arch 2.09 (0.98-4.45) 0.056 0.83 (0.38-1.78) 0.625 
   +Aortic valve 1.56 (0.76-3.22) 0.225 1.11 (0.67-1.48) 0.976 
   +CABG/MVR  2.18 (0.97-4.93) 0.060 1.11 (0.66-1.85) 0.697 
*Indication = dissection/rupture vs elective surgery 
5.4 The relationship between the extent of ATAAD surgery and re-
operation (Study II) 
In study I, a total of 18 patients (cumulative incidence of 3.2%) had a reoperation 
during the same treatment period. Thirteen patients (cumulative incidence 2.3%) 
had a reoperation that was related to index ascending aortic surgery during another 
hospital admission, and four of these patients died due to reoperation. Indications 
for reoperations are listed in Table 7. 
In NORCAAD study (II), we found out that the incidence of reoperation was low. 
In total, 51 (4.5%) individual patients underwent 53 separate reoperations. Five 
patients had both proximal and distal aorta repaired, 3 of them simultaneously. 
Most of the reoperations were elective (69.8%), the rest were either urgent or emer-
gent (30.2%).  
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Table 7. Indications for a reoperation in Study I. 
Indications for reoperation after  
ascending aortic surgery 
Numbers of patients 
Thoracic aortic aneurysm 3 
Abdominal aortic aneurysm 2 
Aortic dissection 2 
Chronic pericarditis 2 
Arrhythmia 
2 
Thoracic aortic rupture 
1 
Abdominal aortic rupture 1 
Mechanical valve infection 1 
Aortic valve stenosis 1 
Mitral valve regurgitation 1 
Coronary artery disease 1 
Coronary artery aneurysm 1 
Unknown 13 
Reoperation details regarding the indications and type of procedures in 51 patients 
are presented in Table 8. There was no significant difference in the risk for distal 
reoperation between the type of distal anastomosis during primary surgery at 1, 5, 
and 8 years (ascending aorta vs. arch involvement; 99.2%, 97.5%, and 95.3% vs 
99.3, 94.8%, and 92.4%, respectively, P = 0.22) (Figure 10). Nor was there signif-
icant difference in the risk for proximal reoperation between the primary root re-
placement group and isolated supracoronary graft technique (98.6%, 97.5%, and 
97.4% vs 98.7%, 97.2%, and 93.8% at 1, 5, and 8 years, respectively; P = 0.84). 
Statistical differences between the distributions of DeBakey type I or II and later 
distal reoperations were not observed either.  
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Table 8.  The indications for reoperations and the procedures performed in 
51 individual patients. Secondary indication or procedures were 
shown in brackets. Modified from the original publication II. 
 Proximal reoperation (n=26)  Distal reoperation (n=30)  
Indications  Procedures  Indication  Procedures  
Severe aortic valve  
insufficiency 
12 Composite graft  16 TAAA 18 TAAA repair 19 
+ Graft infection (2) Valve sparing root  
replacement 
4 Pseudo-aneurysm 9 -TEVAR (4) 
Root dilatation or  
pseudoaneurysm 
9 Supracoronary repair 3 Graft infection 1 -Combination of TEVAR 
and open repair  
(3) 
+ Severe aortic valve 
insufficiency 
(1) Isolated aortic valve 
replacement 
1 Others 2 Hemiarch repair 3 
+ Endocarditis (2) Repair of anastomosis 1   Total arch repair 7 
Graft infection 2 Unknown 1   +Frozen elephant  trunk (3) 
Endocarditis 1     Traditional elephant trunk (1) 
+ Root dilatation (1)     Other 1 
Anastomotic rupture 1       
Root dissection 1       
+ severe aortic valve  
insufficiency, graft 
infection 
(1)       
TAAA = thoracoabdominal aneurysm; TEVAR = thoracic endovascular aortic valve repair  
 
 
 
Figure 10.  The cumulative incidence of reoperations after ATAAD surgery ac-
cording to the initial extent of distal surgery. No significant differ-
ences were detected (P=0.22). Reproduced from the original publi-
cation II with the permission of the copyright holders. 
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The mean follow-up time was 3.3 years (median 2.7; range 0-10 years). Freedom 
from any reoperation was 98.2%, 95%, and 92.3% at 1, 5, and 8 years, respectively. 
Freedom from proximal reoperation was 98.9%, 97.8%, and 96.1% and freedom 
from distal reoperation were 99.2%, 96.9%, and 94.7%at 1, 5, and 8 years, respec-
tively. 
The cumulative survival of patients who underwent a reoperation was 98.0%, 
92.8%, and 88.2% at 1, 5, and 8 years, respectively. Overall, 5 deaths (9.8%) oc-
curred in reoperated patients during follow-up period. The cause of death and in-
dications and procedures for earlier reoperation are presented in Table 9. 
Table 9. Details regarding five patients that died after reoperation. Modified 
from the original publication II. 
 Proximal reoperation Distal reoperation Cause of death 
 Indication Procedure Indication Procedure  
Patient 1. Graft infection Valve sparing root  
replacement 
None None Aortic rupture 
Patient 2. None None TAAA Total arch replacement Postoperative stroke 
Patient 3. None None TAAA Combination of TEVAR 
and open repair 
Sepsis 
Patient 4. None None TAAA Combination of TEVAR and open 
repair 
Postoperative multior-
gan failure 
Patient 5. Root aneurysm, 
endocarditis 
Valve sparing root  
replacement 
TAAA TEVAR Aortic rupture 
TAAA = thoracoabdominal aortic aneurysm; TEVAR = thoracic endovascular aortic valve re-
pair 
In Fine-Gray multivariable regression model with death as a competing risk, the 
extent of the proximal or distal surgery was not associated with the risk of a re-
operation. A history of connective tissue disease increased 5-folds the risk for a 
proximal reoperation (HR 4.99; 95% CI 1.80-13.85; P < 0.01) and was the only 
independent risk factor for a reoperation. 
5.5 Characteristics and outcome in patients with ATAAD and pre-
operative cardiac arrest (Study III) 
Forty-four (3.8%) patients with ATAAD experienced cardiac arrest less than 24 
hours before surgery, and four of them had recurrent episodes of cardiac arrest. 
Unstable hemodynamics was present in 52.3% (n=23) at the beginning of the sur-
gery, and 9 of them had ongoing CPR during initiation of cardiopulmonary bypass.  
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Comparisons between the cardiac arrest group and the non-arrest group are pre-
sented in Table 10. Patients with cardiac arrest had significantly higher intraoper-
ative, in-hospital, and 30-day mortality than those without arrest (Figure 11). In 
logistic regression analysis, arrest patients had 5.3-fold risks for having perioper-
ative myocardial infarction (24.3% vs. 5.7%; OR 5.3; P <0.001). Early complica-
tions, like stroke (48.4% vs. 18.2; OR 4.2; P < 0.001) and new-onset of atrial fi-
brillation (55.9% vs. 38.1%; OR 2.1; P = 0.04), occurred also significantly more 
often in the arrest group. 
Table 10.  Surgically treated type A aortic dissection patients (n=44) com-
pared with non-arrest patients (n=1110). Modified from the manu-
script of study III. 
 Preoperative arrest group Non-arrest group  
 N Median IQR / 
n (%) 
N Median IQR / 
n (%) 
P-
value 
Age (years) 44 66.6 (52.5-71.25) 1100 63.0 (54.0-70.8) 0.67 
Male gender 44 31 (70.5%) 1110 750 (67.6%) 0.75 
Hypotensive shock 44 24 (54.5%) 1026 227 (22.1%) <0.001 
Preoperative cardiac malperfu-
sion 
44 12 (27.3%) 1020 76 (7.5%) <0.001 
Penn classification      
Class A 44 12 (27.3%) 1101 693 (62.9%) <0.001 
Class B 44 2 (4.5%) 1101 244 (22.2%) 0.003 
Class C 44 19 (43.2%) 1101 107 (9.7%) <0.001 
Class B&C 44 11 (25.0%) 1101 57 (5.2%) <0.001 
Preoperative lactate in serum 
(mmol/l) 
30 5.5 (2.4-8.7) 598 1.5 (1.0-2.6) <0.001 
Pericardial tamponade 43 26 (60.5%) 1086 172 (15.8%) <0.001 
Perioperative myocardial infarc-
tion 
37 9 (24.3%) 1084 62 (5.7%) <0.001 
Stroke 31 15 (48.4%) 1088 198 (18.2%) <0.001 
New-onset atrial fibrillation 34 19 (55.9%) 1078 411 (38.1%) 0.04 
IQR = interquartile range; Penn Class A = no ischemia, Class B = localized ischemia, Class C = 
generalized ischemia, Class B&C = localized and generalized ischemia 
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Figure 11.  Patients with ATAAD and preoperative cardiac arrest have signifi-
cantly higher intraoperative, in-hospital and 30-day mortality (all P 
< 0.001). 
 
Figure 12.  Kaplan-Meier curves from Study III showing cumulative survival in 
surgically treated ATAAD with or without preoperative cardiac ar-
rest (P < 0.001).  
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In total, 50% (n=22) of cardiac arrest patients survived the follow-up period.  Daily 
functional ability at the end of the follow-up period was grossly assessed using 
patient records in 15 of the 22 surviving arrest patients. Twelve (80%) of the 15 
cardiac arrest patients were independent in their daily life, and the rest 3 (20%) had 
neurological dysfunctions: one had impaired vision, one had lower limb paresis 
and one was not able to write for unknown reasons. The cumulative survival at 1, 
3 and 5 years was 49.2%, 49.2%, and 49.2% in the cardiac arrest group, and 79.7%, 
76.1%, and 72.1% in the non-arrest group, respectively (Figure 12).  
 
The characteristics of ATAAD patients with preoperative cardiac arrest are pre-
sented in Table 11. Type I DeBakey is associated with 6.2-times and preoperative 
cardiac tamponade with 4.9-times higher hazard of death in patients with preoper-
ative cardiac arrest. Non-survivor were more frequently presented with cardiac 
malperfusion and a higher preoperative lactate level in serum during initial presen-
tation. Survivors in the cardiac arrest group experienced relatively more often an 
out-of-hospital cardiac arrest than non-survivors, although this was not statistically 
significant (Table 12). 
Table 11. The characteristics of ATAAD patients with preoperative cardiac 
arrest. Modified from the manuscript of study III. 
 Number of patients 
N (%) 
Location of the first cardiac arrest episode (n=44)  
Outside hospital 22 (50.0%) 
At the referring hospital 7 (15.9%) 
At the operating hospital 7 (15.9%) 
In the operating room 8 (18.2%) 
Rhythm (n=33)  
Shockable 14 (42.4%) 
Non-shockable 19 (57.6%) 
ROSC (n=32)  
ROSC achieved 25 (78.1%) 
No ROSC before operation 7 (21.9%) 
Unstable haemodynamics* in operating room (n=40) 23 (52.3%) 
Ongoing CPR 9 (22.5%) 
ROSC = return of spontaneous circulation; CPR = cardiopulmonary resuscitation; 
Unstable haemodynamics = systolic pressure < 90 mmHg or ventricular arrhythmia 
or ongoing CPR suring cardiopulmonary bypass initiation 
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Table 12. The characteristics between the survivors and the non-survivors in 
the cardiac arrest group were compared using univariate Cox re-
gression analysis. Modified from the manuscript of study III. 
Non-Survivors 
n = 22 
Survivors 
n = 22 
Univariate Cox regression 
HR (95% CI) 
P-value 
DeBakey type I 89.5% 50.0% 6.21 (1.20-22.67) 0.02 
Pericardial tamponade 81.0% 40.9% 4.94 (1.45-16.85) 0.01 
Cardiac malperfusion 40.9% 13.6% 2.51 (1.06-5.94) 0.04 
Preoperative lactate level 
in serum (mmol/l) 
6.3  
(IQR 4.8-11.8) 
3.4  
(IQR 1.7-7.6) 
1.13 (1.01-1.27)  0.04 
Out-of-operating hospital 
cardiac arrest 
36.4% 63.6% 2.16 (0.93-5.00) 0.11 
HR = hazard ratio     
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6 DISCUSSION 
6.1 Operative incidence and characteristics of TADs 
The number of surgically treated thoracic aortic diseases has been steadily increas-
ing. In our study, the increase was 4.3-fold in women and 2.6-fold in men between 
1968 and 2014, while in a Swedish nationwide registry study, the gender distribu-
tion was similar, but the increase was more significant – 15-fold in women and 7-
fold in men between 1986 and 2002 (Olsson et al., 2006). Instead, the absolute 
operative incidence per 100,000 inhabitants per year was not that different between 
the studies. The trend was also rising when it comes to exclusively operated 
ATAAD. In the NORCAAD registry, the number of operations increased linearly 
from 85 per year in 2005 to 150 per year in 2014 (Geirsson et al., 2018). It is 
noteworthy, however, that our studies did not reflect the overall incidence of tho-
racic aortic diseases in general population as we did not have access to clinical data 
of non-operated patients or autopsy results. 
The characteristics of patients with TAD were mostly similar to the results from 
the world’s largest ATAAD registry, IRAD (Tsai et al., 2006). There was a rather 
steady male-female ratio of 3:1 for ATAAD and 4:1 for combined TADs through-
out the study period, and females were typically older at the time of operation. 
Both registry studies in this thesis showed that the peak of age for undergoing an 
ATAAD surgery was in the patients’ early sixties, and that the patients undergoing 
aortic surgery were significantly older than decades before. This is not surprising 
as not only the understanding of the disease and surgical techniques have evolved 
but, perhaps even more importantly, the perioperative care has taken great leaps 
allowing sicker and older patients to be treated postoperatively (Stevens et al., 
2009). Moreover, better availability and a striking increase in diagnostic imaging 
(Smith-bindman et al., 2009) contribute to not just faster and more accurate diag-
nosis, but also to many incidental findings of indolent aneurysms. These improve-
ments, in turn, directly affect the number of thoracic aortic operations.  
6.2 Outcomes after ascending aortic surgery 
6.2.1 Survival 
The long-term survival after TAD surgery was markedly better in study I than in a 
previous study with a nearly identical setting (Olsson et al., 2006). Notably, our 
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results combine both elective and emergent aortic repairs, which differ considera-
bly from each other in the initial presentation, the time for surgical preparation, the 
quality of the tissues and in particular, the risks that the surgery carries. Study I 
showed that an ascending aortic dissection or rupture indicated a nearly 4-fold risk 
for 30-day mortality compared to elective procedures. What was interesting, how-
ever, was that the very long-term survival did not significantly differ between elec-
tively and emergently repaired TAD groups in 30-day survivors. This indicates 
that even if ATAAD has a dramatic initial presentation with high mortality, once 
the aorta is repaired and the patient has survived the first critical month postoper-
atively, the survival stabilizes and is reasonably satisfying. 
The survival after ATAAD surgery in the NORCAAD registry was comparable to 
other notable large registries in recent years (Conzelmann et al., 2016; Pape et al., 
2007). Compared to older studies, however, the survival was better throughout the 
current study period (Ehrlich et al., 2000; Knipp et al., 2007). From 2005 to 2014, 
the 30-day mortality has significantly decreased within the NORCAAD registry 
(Geirsson et al., 2018). In one of the NORCAAD sub-studies, the survival of 30-
day survivors was compared to a large normal age- and gender-matched population 
in Sweden, and a worse survival was noted within ATAAD group compared to 
matched population (Olsson et al., 2017). Same finding has been noted before 
(Bekkers et al., 2012), albeit in a NORCAAD study, where the difference between 
the groups was modest and seemed to be effaced and stabilized over time, which 
also supports the survival findings that was noted in Study I. In study I, however, 
the era of surgery did not have an effect on very long-term mortality. These find-
ings suggest that the acute management and perioperative care of ATAAD have 
significantly improved in the 21st century which has resulted in both better short 
and mid-term results. Nonetheless, longer follow-ups in large registries are needed 
before assumptions regarding long-term survival can be made. 
6.2.2 Predictors for mortality 
For 30-day mortality after TAD surgery, the era of surgery and increased age were 
found to be independent predictors. For those who survived 30 days after TAD 
surgery, the only independent predictor for mid-term mortality was increasing age. 
In the NORCAAD registry, 30-day mortality was highest among those that expe-
rienced cardiac (32.8%), gastrointestinal (30.8%), or cerebral (26.4%) malperfu-
sion (Zindovic et al., 2019). Increased age, a history of chronic renal disease, car-
diac malperfusion and previous aortic surgical repair were independent predictors 
of mid-term mortality, whereas a heritable condition, open distal anastomosis, and 
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a surgery at a later year/later period were independently associated with better me-
dium-term survival (Olsson et al., 2017). Although higher age seems to be an in-
dependent predictor in both registries, previous studies have shown that in-hospital 
complications did not differ between ≥ 70 and < 70 years old. In fact, within ≥ 70 
years, the survival was superior in the surgically treated group compared to the 
medically treated, and over 75 years were noted to have acceptable early and in-
termediate survival after ATAAD surgery as well (Malvindi et al., 2015; Mehta et 
al., 2002). Therefore, although risks might be higher, patients with advanced age 
alone should not be considered less suitable for surgical repair. 
6.3 The relationship between the extent of primary ATAAD sur-
gery and reoperations  
The reoperation rates from both Turku University Hospital and the NORCAAD 
study were notably lower than in most previous studies (Bekkers et al., 2012; 
Geirsson et al., 2007; Trimarchi et al., 2005), yet early and mid-term mortality after 
primary ATAAD surgery, and mortality after reoperations were still comparable 
with other large registry studies. 
The extent of primary repair of ATAAD is an ongoing debate among aortic sur-
geons. There are many studies that speak on behalf of a more aggressive surgical 
approach during initial ATAAD repair in order to reduce risks for later aortic di-
latations and reinterventions (Bartolomeo et al., 2015; Moon et al., 2001; Sun et 
al., 2011; Weigang et al., 2010). Equally, there are studies that were more cautious 
and would favour a more conservative approach (Poon et al., 2016a; Rylski et al., 
2014; Wang et al., 2017). Our studies support the latter one. In addition to low 
overall reoperation rates, the NORCAAD registry also showed that the extent of 
proximal or distal primary surgery did not affect the incidence of reoperations, nor 
did the extent of the dissection (DeBakey type I vs. II). Moreover, in Study I, there 
was a tendency towards a more aggressive approach, such as arch involvement or 
concomitant CABG/MVR, increasing the risk for 30-day mortality. In general, the 
surgical approaches in our studies were rather conservative compared to other 
studies (Conzelmann et al., 2016; Geirsson et al., 2007). The distribution of 
DeBakey type I and II (73% and 26%, respectively) was similar to others, albeit 
the proportion of total arch replacement (5.9%) was less frequent than other studies 
have reported (Conzelmann et al., 2016; Eusanio et al., 2013; Geirsson et al., 
2007). Nevertheless, the median follow-up time is limited to 3.3 years in the NOR-
CAAD registry, which is shorter than in many other studies. The need for reinter-
ventions may emerge many years after primary surgery and, therefore, longer fol-
low-ups are still warranted, and our results cannot be interpreted directly. 
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Isolated supracoronary aortic replacement with intimal tear resection is considered 
the simplest and safest way to repair ATAAD (Westaby et al., 2002). More ag-
gressive initial approaches, like total arch repairs with or without frozen elephant 
trunk (a hybrid prosthesis that consists of a distal endovascular stent graft and a 
proximal conventional surgical graft), are not only highly demanding procedures 
but also very time-consuming, associated oftentimes with a much longer operating 
time, CPB time, aortic cross-clamp time, HCA time, and requiring selective cere-
bral perfusion, which are all associated with higher postoperative complications 
and early mortality (Bekkers et al., 2012; Hata et al., 2010; Schoenrath et al., 2016; 
Tan et al., 2003). As our studies have shown, early mortality is still remarkable 
despite having significantly improved over time. In short, the operative risk in-
creases steadily with complexity and duration, and therefore, the primary objective 
and ultimate goal during surgery would be to do only what is absolutely necessary 
to repair the aorta and restore perfusion in order to come out of the operating room 
with a stable, alive patient. 
It is worth noting that a reoperation after ascending aortic surgery is also a complex 
and challenging procedure due to variations in clinical and anatomical features, 
and abundant scar tissue that has formed after primary surgery. Naturally, another 
risky open cardiac surgery is also an undesired setback for the patient.  Study II 
showed that most indications for distal reoperations were pseudoaneurysms due to 
progressive enlargement of the persistent false lumen or suture dehiscence which 
is in accordance with previously reported results (Hsu & Chen, 2014; Kobuch et 
al., 2012). It has been suggested that by treating the residual false lumen at the 
index operation when the dissection extends to the aortic arch or beyond (DeBakey 
type I), long-term prognosis may be more favourable as the risk for reoperations 
might be lower. In recent years, acceptable early results have been presented after 
a more extensive initial repair during ATAAD (Omura et al., 2016; Poon et al., 
2016a; Smith et al., 2017b) suggesting that an extensive primary repair can be 
safely performed to avoid late reoperations. Some centres have even introduced 
total arch repair with frozen elephant trunk as the standard treatment for aortic arch 
repair (Geirsson et al., 2007; Sun et al., 2011). Nevertheless, these results are from 
high-volume centres with expertise in aortic surgeries, and long-term outcomes are 
yet not well established.  
The incidence of ATAAD is fairly low, but when it occurs, it almost always results 
in an emergent surgery. High-volume aortic centres might have a separate acute 
aortic syndrome team but most centres in the world are small-to-medium sized, 
thus annual number of encountered ATAAD per surgeon in these centres remains 
limited, and these operations are often performed by on-call cardiac surgeons who 
might not be the most experienced aortic surgeons in the centre. Therefore, it re-
mains at the surgeon’s discretion to evaluate his or hers and the team’s competence 
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and to choose the procedure they feel comfortable in safely performing, while con-
sidering in the decision-making the patient’s comorbidities and presentation.  
The only independently significant risk factor for a late proximal reoperation was 
a history of connective tissue disease. Therefore, in the presence of aortic root en-
largement in patients with known connective tissue disease, the threshold for con-
comitant root operation should be lower. 
All in all, there is little evidence for advocating routine adoption of complex ex-
tensive primary surgical strategies for ATAAD in low- to medium-volume centres. 
Based on the existing literature and studies I and II, there is little to be gained by 
choosing an unfamiliar and complex but definitive repair over a simpler, more 
conservative approach. However, the findings based on our studies are encourag-
ing: good surgical results with low reoperation rate and acceptable reoperation sur-
vival can be achieved in non-aortic centralized cardiothoracic centres with moder-
ately simple approaches.  
6.4 Surgically treated ATAAD in patients with preoperative car-
diac arrest 
Study III focused on ATAAD patients that experienced a cardiac arrest < 24 hours 
before the surgery. Our study revealed a novel finding that, despite perceived dis-
mal prognosis in these patients, up to 50% survive in the long-term and experience 
an acceptable functional recovery.  
In the NORCAAD registry, the incidence of preoperative cardiac arrest was 3.8% 
(44/1154) among surgically treated patients with ATAAD. Most previous studies 
reviewed the incidence and outcome of ATAAD among all cardiac arrest patients, 
which is essentially a different population to that of Study III. A retrospective study 
from an emergency department in a single centre reported that 1.0% out of all in- 
or out-of-hospital cardiac arrests were caused by non-traumatic thoracic aortic dis-
sections (Meron et al., 2004). However, the incidence of aortic dissection/rupture 
is significantly higher among those that died after out-of-hospital cardiac arrests, 
and studies involving either post-morten CT or autopsies have higher rates of aortic 
dissection/rupture than the studies without them (Tanaka et al., 2016; Virkkunen 
et al., 2008). Previous studies with post-mortem CT analysis revealed that up to 7-
8% of all out-of-hospital cardiac arrest patients were caused by ATAAD, and 51% 
of these patients died pre-hospital (Moriwaki et al., 2013; Tanaka et al., 2016). It 
is therefore plausible that the incidence of patients with ATAAD and preoperative 
cardiac arrest in the general population is much higher than study III has reported.  
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In the present study, half of the patients experienced a cardiac arrest out-of-hospi-
tal, which means the diagnosis was made post hoc. Ironically, survival after out-
of-hospital cardiac arrest seems to be better than after in-hospital arrest, although 
the difference was not statistically significant (63.6% vs. 36.4%, p=0.11). Instead, 
non-survivors in cardiac arrest group had more often malperfusion syndrome and 
DeBakey type I dissection, which is in line with other studies on ATAAD in gen-
eral (Eusanio et al., 2013; Narayan et al., 2017; Zindovic et al., 2018). It is also 
noteworthy that one-third of patients (3/9) that had ongoing CPR during cardio-
pulmonary bypass initiation did actually survive till the end of follow-up. How-
ever, the number of patients with ongoing preoperative CPR was so small that it is 
not reasonable to make further extrapolations. 
Having no deaths among cardiac arrest patients after the 65th postoperative day 
might be coincidental, yet it still alludes to the same findings noticed in all three 
sub-studies: the initial mortality is high in ATAAD, but survival stabilises substan-
tially after the first months. Cumulative survival in ATAAD patients with preoper-
ative cardiac arrest at 5 years being 49.2% is acceptable. In particular, recovery 
among survivors was notably better than expected; only one patient needed daily 
assistance for independent living. These results were substantially better than the 
findings of a previous study with a similar design which reported only a 13% hos-
pital survival after surgically treated ATAAD in patients with preoperative cardiac 
arrest (Godon et al., 2001). 
Although these survival results might be encouraging, one should bear in mind that 
there already was a patient selection process before the decision to operate. Pa-
tients with prolonged arrest time or otherwise assessed as having no chance of 
neurological recovery were most likely already denied surgery. From a surgeon’s 
point of view, however, it is important to rationally understand how the patient 
selection was made and to have objective data regarding long-term survival in pa-
tients with ATAAD and preoperative cardiac arrest, instead of making decisions 
based on intuition. As the number of these patients is very limited, a large database 
such as the NORCAAD registry, adds valuable details to the literature. Nonethe-
less, due to limitations of the study, prospective studies are needed to better under-
stand the course of ATAAD with preoperative cardiac arrest and to determine 
when surgery adds value and when it only prolongs suffering. 
6.5 Limitations and strengths 
A study can only be as good as the data it is based on. All studies were based on 
variables collected from patient records which have many limitations due to the 
retrospective observational nature. There were some data that were missing and 
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could not be tracked subsequently. Moreover, only surgically treated patients were 
included which may cause selection bias since the patients that did not survive to 
the hospital or were denied surgery were unaccounted for. There is a risk of statis-
tical analyses being underpowered and entangled by unknown confounders. In 
NORCAAD multicentre studies, the protocols of each centre differ to some extent. 
At the end, the decision to operate and the procedure to be performed always de-
pends on the experience and preference of the surgeon, the perioperative team and 
the facilities the centre provides. In study I, the exact indications for elective as-
cending aortic operations were not known, although it is presumable that other 
indications than ascending aortic aneurysm were very marginal. Study II was also 
limited by a relatively short follow-up time, the paucity of radiologic data and lim-
ited number of reoperated patients. In addition, there’s a possibility for false neg-
atives as some patients may succumb before a reoperation is needed. In study III, 
the study sample of preoperative cardiac arrest patients was small making multi-
variable regression model unreliable to conduct. In addition, although we have a 
complete mortality data, the exact cause of death was unknown and therefore, the 
causality from the results should be interpreted with caution. 
The strength of these studies is the completeness of the data. In NORCAAD stud-
ies, all the centres involved were low-to-medium sized academic institutions. The 
Nordic countries are similar in many ways, including electronic medical records, 
high standards of health care, similar universal health care systems, equivalent car-
diothoracic surgical training programs, homogenous populations, and similar geo-
graphical population distributions. Above all, nearly complete mortality data were 
provided by each country’s government-funded national registries. Furthermore, 
Study I depicted comprehensively the trend and evolutions as it had a very long 
follow-up spanning over six decades. The study also covered all consecutive TADs 
ever operated in Turku University Hospital, and the centre remained the only ter-
tiary cardiothoracic centre throughout the study period in this region. These ele-
ments together provide prerequisites for comprehensive and reliable data registries 
that mirror the real-life challenges, and yield results that can be applied to daily 
clinical work. 
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7 CONCLUSIONS 
The following conclusions can be drawn from the present study: 
I. The number of TAD operations has significantly increased and the sur-
gical results have improved in 47 years. After the initial critical 30-days, 
the long-term survival did not significantly differ between the group 
treated for ATAAD/rupture and the group treated for ascending aortic 
aneurysm.  
II. The risk for reoperation after ATAAD surgery was low in the Nordic 
countries. Isolated ascending aortic replacement during the primary 
ATAAD repair did not increase the cumulative incidence for a later re-
operation in comparison to arch involvement. 
III. Surgically treated ATAAD with preoperative cardiac arrest had high 
rates of complications and early mortality rates. However, mid-term out-
come was acceptable. A preoperative cardiac arrest in patients with 
ATAAD should not be considered as an absolute contraindication for a 
surgical repair. 
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